https://www.pembrokeconsulting.com/epipen-channel-economics-and-the-great-pbm-rebate-debate-2/2016-09-26T13:04:27+00:00https://www.pembrokeconsulting.com/epipen-channel-economics-and-the-great-pbm-rebate-debate-3/2016-09-26T13:04:09+00:00https://www.pembrokeconsulting.com/epipen-channel-economics-and-the-great-pbm-rebate-debate/2016-09-30T10:54:08+00:00https://www.pembrokeconsulting.com/life-sciences-trade-and-channel-strategies-2016/2016-10-05T13:42:52+00:00https://www.pembrokeconsulting.com/2015s-fastest-growing-private-specialty-pharmacies-from-the-inc-5000/2016-10-05T13:41:57+00:00https://www.pembrokeconsulting.com/real-world-evidence-market-access-usa-2016/2016-10-05T13:39:56+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-september-2016-walgreens-specialty-pharmacy-cvs-caremark-drug-spending-theranos-and-an-epipen-joke/2016-09-23T13:17:57+00:00https://www.pembrokeconsulting.com/specialty-product-data-strategies/2016-10-11T11:35:52+00:00https://www.pembrokeconsulting.com/walgreens-tricare-win-tracking-wbas-aggressive-preferred-network-deal-strategy/2016-10-06T13:19:51+00:00https://www.pembrokeconsulting.com/exclusive-preferred-pharmacy-networks-are-back-in-85-of-the-2017-medicare-part-d-plans/2016-10-05T11:39:15+00:00https://www.pembrokeconsulting.com/aco-population-health-congress/2016-10-17T15:55:52+00:00https://www.pembrokeconsulting.com/follow-the-vial-the-buy-and-bill-system-for-distribution-and-reimbursement-of-provider-administered-outpatient-drugs/2016-10-14T11:39:21+00:00https://www.pembrokeconsulting.com/follow-the-dollar-measuring-who-profits-from-a-brand-name-prescription/2016-10-13T11:34:10+00:00https://www.pembrokeconsulting.com/employer-pharmacy-benefits-in-2016-more-specialty-drug-cost-shifting-means-more-problems-for-patients/2016-10-18T11:07:46+00:00https://www.pembrokeconsulting.com/the-2016-economic-report-on-retail-mail-and-specialty-pharmacies/2016-10-25T07:24:47+00:00https://www.pembrokeconsulting.com/the-2016-17-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2016-10-25T10:56:20+00:00https://www.pembrokeconsulting.com/the-top-specialty-drug-distributors-in-2015/2016-10-20T12:11:35+00:00https://www.pembrokeconsulting.com/real-world-data-for-competitive-advantage-summit/2016-10-24T11:31:49+00:00https://www.pembrokeconsulting.com/walgreens-plays-to-win-our-exclusive-analysis-of-2017s-part-d-preferred-pharmacy-networks/2016-10-25T11:35:46+00:00https://www.pembrokeconsulting.com/follow-the-dollar-the-movie/2016-10-28T11:31:57+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-october-2016-gross-to-net-bubble-part-d-rebates-epipen-and-mckesson/2016-10-27T11:33:06+00:00https://www.pembrokeconsulting.com/what-mckessons-profit-warning-means-for-manufacturers-and-pharmacies/2016-10-31T11:46:00+00:00https://www.pembrokeconsulting.com/how-payers-profit-from-drug-price-inflation-the-strange-case-of-epipen-and-cvs-health/2016-11-03T23:50:20+00:00https://www.pembrokeconsulting.com/an-important-correction-to-yesterdays-post/2016-11-04T17:09:47+00:00https://www.pembrokeconsulting.com/reimbursement-and-contracting-conference/2016-11-08T02:22:44+00:00https://www.pembrokeconsulting.com/behind-diplomat-pharmacys-plunge-a-primer-on-dir-fees-in-medicare-part-d/2016-11-08T12:49:32+00:00https://www.pembrokeconsulting.com/cvs-drugstore-profits-suffer-as-walgreens-partners/2016-11-10T12:52:58+00:00https://www.pembrokeconsulting.com/genentechs-shocking-2-billion-340b-revelation/2016-11-15T12:36:10+00:00https://www.pembrokeconsulting.com/specialty-therapies-2017/2016-11-14T12:49:13+00:00https://www.pembrokeconsulting.com/will-president-trump-eliminate-the-dscsa/2016-11-11T12:42:36+00:00https://www.pembrokeconsulting.com/a-post-election-projection-the-2025-payer-market-for-prescription-drugs/2016-11-17T12:54:37+00:00https://www.pembrokeconsulting.com/cbis-12th-life-sciences-trade-and-channel-strategies/2016-11-21T12:44:14+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-november-2016-cvs-caremark-generic-drugs-health-system-pharmacies-and-the-fda/2016-11-29T11:44:55+00:00https://www.pembrokeconsulting.com/expanded-access-programs-2017/2016-11-28T12:44:30+00:00https://www.pembrokeconsulting.com/cvs-changes-direction-with-surprise-optumrx-deal/2016-11-30T12:45:56+00:00https://www.pembrokeconsulting.com/novo-nordisk-sheds-new-light-on-pbm-rebates-the-gross-to-net-bubble-and-warped-channel-incentives/2016-12-06T19:12:26+00:00https://www.pembrokeconsulting.com/cbis-8th-hub-and-spp-model-optimization/2016-12-05T12:56:45+00:00https://www.pembrokeconsulting.com/plan-sponsors-like-more-transparent-pbms-yet-not-all-choose-transparency/2016-12-08T12:35:45+00:00https://www.pembrokeconsulting.com/the-2nd-annual-government-programs-summit/2016-12-12T11:31:40+00:00https://www.pembrokeconsulting.com/new-data-show-prescription-profits-under-pressure-at-independent-pharmacies/2016-12-13T12:14:53+00:00https://www.pembrokeconsulting.com/five-industry-trends-for-u-s-drug-wholesalers-in-2017/2016-12-15T12:51:15+00:00https://www.pembrokeconsulting.com/things-to-watch-in-2017s-drug-channels/2016-12-16T12:38:41+00:00https://www.pembrokeconsulting.com/partnering-with-idns-biopharma-strategy-summit/2016-12-19T12:43:49+00:00https://www.pembrokeconsulting.com/my-visit-to-boots-uk-an-international-pharmacy-photo-essay-rerun/2016-12-20T12:45:15+00:00https://www.pembrokeconsulting.com/why-the-walgreensprime-deal-could-transform-the-pbm-industry-rerun/2016-12-21T12:43:55+00:00https://www.pembrokeconsulting.com/follow-the-dollar-measuring-who-profits-from-a-brand-name-prescription-rerun/2016-12-23T12:49:15+00:00https://www.pembrokeconsulting.com/how-specialty-pharmacy-is-penetrating-buy-and-bill-oncology-channels-rerun/2016-12-22T12:46:27+00:00https://www.pembrokeconsulting.com/video-blog/2017-01-03T12:33:08+00:00https://www.pembrokeconsulting.com/spcma-business-forum-2017/2017-01-03T12:55:13+00:00https://www.pembrokeconsulting.com/specialty-pharmacy-ma-our-look-at-2016s-deals/2017-01-04T13:07:27+00:00https://www.pembrokeconsulting.com/14th-annual-world-health-care-congress/2017-01-09T14:15:56+00:00https://www.pembrokeconsulting.com/yes-commercial-payers-are-adopting-narrow-retail-pharmacy-networks/2017-01-11T12:31:58+00:00https://www.pembrokeconsulting.com/pbmi-22nd-annual-drug-benefit-conference/2017-01-17T12:48:45+00:00https://www.pembrokeconsulting.com/new-2017-part-d-enrollment-data-walgreens-and-walmart-trounce-cvs-in-preferred-networks/2017-01-18T13:03:19+00:00https://www.pembrokeconsulting.com/pap-2017-cbis-18th-annual-patient-assistance-access-programs/2017-01-23T12:33:37+00:00https://www.pembrokeconsulting.com/the-weird-and-wild-gross-to-net-adventures-of-epipen-and-its-alternatives/2017-01-24T17:01:02+00:00https://www.pembrokeconsulting.com/mckessons-profit-shortfall-how-wholesalers-benefit-from-rising-drug-list-prices/2017-01-26T14:06:29+00:00https://www.pembrokeconsulting.com/cbis-4th-annual-e-rx-and-ehr-forum-eprescribing-and-electronic-health-records/2017-01-30T12:41:26+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-january-2017-gross-to-net-details-part-b-diplomat-cvs-health-andthis-site/2017-01-31T12:37:07+00:00https://www.pembrokeconsulting.com/dir-fees-rebates-pharmacy-economics-and-the-future-of-medicare-part-d/2017-02-01T12:01:00+00:00https://www.pembrokeconsulting.com/the-top-15-u-s-pharmacies-of-2016/2017-02-02T12:37:39+00:00https://www.pembrokeconsulting.com/new-the-2017-economic-report-on-u-s-pharmacies-and-pharmacy-benefit-managers/2017-02-07T12:42:36+00:00https://www.pembrokeconsulting.com/cbis-formulary-co-pay-and-access-summit/2017-02-13T12:39:22+00:00https://www.pembrokeconsulting.com/express-scripts-reveals-what-really-drives-drug-spending-and-why-the-government-may-do-no-better/2017-02-14T12:44:12+00:00https://www.pembrokeconsulting.com/retail-clinic-check-up-cvs-retrenches-walgreens-outsources-kroger-expands/2017-02-16T12:51:03+00:00https://www.pembrokeconsulting.com/join-me-at-asembias-specialty-pharmacy-summit-2017/2017-02-21T14:43:48+00:00https://www.pembrokeconsulting.com/the-top-15-specialty-pharmacies-of-2016/2017-02-22T12:43:25+00:00https://www.pembrokeconsulting.com/eyeforpharma-oncology-market-access-pricing-2017/2017-02-27T07:06:25+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-february-2017-specialty-pharmacy-x2-pbms-in-medicare-and-health-insurance-hilarity/2017-02-28T12:38:36+00:00https://www.pembrokeconsulting.com/new-cms-forecast-lower-drug-spending-growth/2017-03-02T12:49:48+00:00https://www.pembrokeconsulting.com/watch-congress-vent-about-pbms-on-the-house-floor/2017-03-03T12:35:14+00:00https://www.pembrokeconsulting.com/the-u-s-health-care-congress-2017/2017-03-06T12:48:45+00:00https://www.pembrokeconsulting.com/the-new-health-transformation-alliance-deal-mostly-good-for-pbms-but-bad-for-express-scripts/2017-03-07T12:41:51+00:00https://www.pembrokeconsulting.com/janssen-reveals-and-explains-its-list-and-net-drug-pricing/2017-03-09T12:46:31+00:00https://www.pembrokeconsulting.com/19th-annual-medicaid-and-government-pricing-congress/2017-03-13T11:41:07+00:00https://www.pembrokeconsulting.com/scott-gottliebs-radical-idea-for-disrupting-u-s-drug-channels-implications-for-pbms-wholesalers-and-pharmacies/2017-03-14T22:30:56+00:00https://www.pembrokeconsulting.com/cbis-real-time-benefit-check-and-eprior-authorization-summit/2017-03-20T11:46:34+00:00https://www.pembrokeconsulting.com/which-pbm-best-managed-drug-spending-in-2016-cvs-health-express-scripts-medimpact-or-prime/2017-03-21T18:56:29+00:00https://www.pembrokeconsulting.com/five-questions-to-ask-when-selling-your-pharmacy/2017-03-24T16:50:50+00:00https://www.pembrokeconsulting.com/world-congress-manufacturers-340b-summit/2017-03-27T11:47:59+00:00https://www.pembrokeconsulting.com/a-tale-as-old-as-time-examining-employer-pbm-rebate-relationships-for-specialty-drugs/2017-03-28T11:42:04+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-march-2017-eli-lilly-cvs-health-novo-nordisk-and-specialty-pharmacies/2017-03-30T11:40:06+00:00https://www.pembrokeconsulting.com/pcma-pbm-policy-forum-2017/2017-04-03T14:36:36+00:00https://www.pembrokeconsulting.com/latest-data-show-that-hospitals-are-still-specialty-drug-profiteers/2017-04-04T12:40:56+00:00https://www.pembrokeconsulting.com/for-walgreens-narrow-network-pbm-partnering-pays-off/2017-04-06T12:08:54+00:00https://www.pembrokeconsulting.com/health-systems-disrupt-the-specialty-pharmacy-market-to-improve-patient-care/2017-04-07T11:58:07+00:00https://www.pembrokeconsulting.com/medicaid-drug-rebate-program-summit/2017-04-10T11:40:17+00:00https://www.pembrokeconsulting.com/our-exclusive-2021-outlook-for-specialty-pharmacy-prescription-revenues/2017-04-11T11:35:15+00:00https://www.pembrokeconsulting.com/exclusive-update-the-state-of-specialty-pharmacy-accreditation-in-2017/2017-04-13T13:39:24+00:00https://www.pembrokeconsulting.com/how-to-connect-with-drug-channels-at-asembia17/2017-04-17T11:45:06+00:00https://www.pembrokeconsulting.com/cardinal-healths-unhappy-profit-surprise-the-coevolution-of-pharmacy-buying-groups-and-wholesaler-economics/2017-04-19T16:33:31+00:00https://www.pembrokeconsulting.com/how-manufacturers-can-benefit-from-unified-specialty-support-services/2017-04-21T12:04:35+00:00https://www.pembrokeconsulting.com/cbis-13th-commercial-contract-chargeback-excellence/2017-04-24T11:48:16+00:00https://www.pembrokeconsulting.com/which-pbm-best-managed-drug-spending-in-2016-how-did-optumrx-compare/2017-04-25T11:39:51+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-april-2017-teva-diplomat-pharmacy-oncology-practices-and-starbucks/2017-04-27T11:40:50+00:00https://www.pembrokeconsulting.com/building-the-infrastructure-for-outcomes-based-contracts/2017-04-28T12:01:19+00:00https://www.pembrokeconsulting.com/dir-fees-rebates-pharmacy-economics-and-the-future-of-medicare-part-d-rerun/2017-05-02T07:12:12+00:00https://www.pembrokeconsulting.com/the-top-15-u-s-pharmacies-of-2016-rerun/2017-05-01T12:17:53+00:00https://www.pembrokeconsulting.com/plan-sponsors-like-more-transparent-pbms-yet-not-all-choose-transparency-rerun/2017-05-03T08:03:08+00:00https://www.pembrokeconsulting.com/five-industry-trends-for-u-s-drug-wholesalers-in-2017-rerun/2017-05-04T21:55:11+00:00https://www.pembrokeconsulting.com/the-weird-and-wild-gross-to-net-adventures-of-epipen-and-its-alternatives-rerun/2017-05-05T11:42:53+00:00https://www.pembrokeconsulting.com/the-state-of-specialty-pharmacy-2017-reflections-from-asembia17/2017-05-09T10:41:35+00:00https://www.pembrokeconsulting.com/what-i-told-hhs-secretary-tom-price-about-the-340b-drug-pricing-program/2017-05-11T11:51:59+00:00https://www.pembrokeconsulting.com/three-misconceptions-about-channel-strategy/2017-05-12T16:46:49+00:00https://www.pembrokeconsulting.com/medicaid-drug-rebate-program-mdrp-summit-2017/2017-05-15T11:41:04+00:00https://www.pembrokeconsulting.com/five-fun-facts-about-the-new-express-scripts-goodrx-drug-discount-partnership/2017-05-16T11:52:12+00:00https://www.pembrokeconsulting.com/exclusive-the-340b-program-hits-16-2-billion-in-2016-now-5-of-u-s-drug-market/2017-05-18T11:56:03+00:00https://www.pembrokeconsulting.com/340b-purchases-were-more-than-half-of-the-hospital-market-in-2016/2017-05-19T11:42:05+00:00https://www.pembrokeconsulting.com/join-me-at-the-world-congress-pharma4-event/2017-05-22T11:42:23+00:00https://www.pembrokeconsulting.com/a-reality-check-on-amazons-pharmacy-ambitions/2017-05-23T11:37:34+00:00https://www.pembrokeconsulting.com/cbis-summit-on-gpo-membership-eligibility-and-class-of-trade-maintenance/2017-05-30T11:47:10+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-may-2017-express-scripts-wbad-dir-fees-jama-and-asembia17-photos/2017-05-31T11:45:14+00:00https://www.pembrokeconsulting.com/patient-assistance-programs-why-pharmaceutical-manufacturers-operate-the-biggest-u-s-charities/2017-06-01T11:47:35+00:00https://www.pembrokeconsulting.com/reimbursement-and-access-2017/2017-06-05T11:48:16+00:00https://www.pembrokeconsulting.com/latest-data-on-pharmacy-markets-evolution-the-real-story-behind-the-retail-vs-mail-battle/2017-06-06T11:43:38+00:00https://www.pembrokeconsulting.com/average-pharmacist-salaries-hit-120000-but-growth-again-lags-other-healthcare-professions/2017-06-08T11:35:06+00:00https://www.pembrokeconsulting.com/trends-and-challenges-in-specialty-drugs/2017-06-09T11:13:28+00:00https://www.pembrokeconsulting.com/cbis-annual-340b-manufacturer-summit/2017-06-12T11:12:33+00:00https://www.pembrokeconsulting.com/new-data-show-the-gross-to-net-rebate-bubble-growing-even-bigger/2017-06-14T12:03:07+00:00https://www.pembrokeconsulting.com/will-cvs-healths-point-of-sale-rebates-deflate-the-gross-to-net-bubble-and-disrupt-the-pbm-business/2017-06-15T11:13:47+00:00https://www.pembrokeconsulting.com/cbis-specialty-pharmacy-network-design-summit/2017-06-19T11:40:03+00:00https://www.pembrokeconsulting.com/profits-in-the-2017-fortune-500-manufacturers-vs-wholesalers-pbms-and-pharmacies/2017-06-20T13:38:43+00:00https://www.pembrokeconsulting.com/insider-tips-to-help-meet-patient-management-standards-in-uracs-specialty-pharmacy-v3-0-accreditation/2017-06-23T14:06:24+00:00https://www.pembrokeconsulting.com/cbis-9th-hub-and-spp-model-optimization/2017-06-26T11:23:07+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-june-2017-amazon-whole-foods-340b-dir-fees-provider-sponsored-health-plans-and-kaiser/2017-06-27T11:14:28+00:00https://www.pembrokeconsulting.com/observations-on-the-new-walgreens-boots-alliance-rite-aid-deal/2017-06-30T11:20:09+00:00https://www.pembrokeconsulting.com/five-fun-facts-about-the-new-express-scripts-goodrx-drug-discount-partnership-rerun/2017-07-05T06:12:46+00:00https://www.pembrokeconsulting.com/cardinal-healths-unhappy-profit-surprise-the-coevolution-of-pharmacy-buying-groups-and-wholesaler-economics-rerun/2017-07-06T07:39:10+00:00https://www.pembrokeconsulting.com/what-i-told-hhs-secretary-tom-price-about-the-340b-drug-pricing-program-rerun/2017-07-07T11:39:42+00:00https://www.pembrokeconsulting.com/medicaid-drug-rebate-program-summit-2017/2017-07-10T11:39:35+00:00https://www.pembrokeconsulting.com/the-booming-340b-contract-pharmacy-profits-of-walgreens-cvs-rite-aid-and-walmart/2017-07-11T11:14:41+00:00https://www.pembrokeconsulting.com/10-hospitals-with-340b-contract-pharmacy-mega-networks/2017-07-13T11:23:10+00:00https://www.pembrokeconsulting.com/cbis-life-sciences-outcomes-based-contracting-summit/2017-07-17T11:41:36+00:00https://www.pembrokeconsulting.com/understanding-cmss-surprising-reimbursement-cut-for-340b-hospitals/2017-07-18T14:23:36+00:00https://www.pembrokeconsulting.com/2016s-top-retail-pharmacy-chains-according-to-drug-store-news/2017-07-20T11:48:47+00:00https://www.pembrokeconsulting.com/pbmi-2017-specialty-rx-forum/2017-07-24T10:49:53+00:00https://www.pembrokeconsulting.com/what-will-happen-to-rite-aids-struggling-envisionrx-pbm/2017-07-25T11:00:46+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-july-2017-cvs-anthem-specialty-pharmacy-insys-and-big-box-pharmacy/2017-07-27T11:37:07+00:00https://www.pembrokeconsulting.com/cbis-5th-annual-coupon-and-copay/2017-07-31T11:26:47+00:00https://www.pembrokeconsulting.com/new-part-b-buy-and-bill-data-physician-offices-are-losing-to-hospital-outpatient-sites/2017-08-01T11:27:43+00:00https://www.pembrokeconsulting.com/whats-in-whats-out-the-new-2018-cvs-health-and-express-scripts-formulary-exclusion-lists-plus-a-sneak-peek-from-prime/2017-08-03T11:39:08+00:00https://www.pembrokeconsulting.com/cbis-pap-legal-update/2017-08-07T11:46:42+00:00https://www.pembrokeconsulting.com/follow-the-dollar-math-how-much-do-pharmacies-wholesalers-and-pbms-make-from-a-prescription/2017-08-08T16:22:22+00:00https://www.pembrokeconsulting.com/generic-deflation-roils-the-channel-and-will-get-worse/2017-08-10T11:36:13+00:00https://www.pembrokeconsulting.com/electronic-benefit-verification-prior-authorization-summit/2017-08-14T11:35:34+00:00https://www.pembrokeconsulting.com/diplomat-sees-declining-dir-fee-impact-and-perhaps-readies-a-pbm-strategy/2017-08-16T11:28:39+00:00https://www.pembrokeconsulting.com/cbis-gross-to-net-summit/2017-08-21T11:22:22+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-august-2017-amazon-express-scripts-walgreens-pharmerica-rebates-and-bezos-business-wisdom/2017-08-22T11:21:08+00:00https://www.pembrokeconsulting.com/4th-annual-rare-disease-market-access-and-commercialization-summit/2017-08-28T11:30:23+00:00https://www.pembrokeconsulting.com/profits-in-the-2017-fortune-500-manufacturers-vs-wholesalers-pbms-and-pharmacies-rerun/2017-08-29T11:53:20+00:00https://www.pembrokeconsulting.com/which-pbm-best-managed-drug-spending-in-2016-cvs-health-express-scripts-medimpact-or-prime-rerun/2017-08-30T11:23:16+00:00https://www.pembrokeconsulting.com/a-reality-check-on-amazons-pharmacy-ambitions-rerun/2017-08-31T11:33:37+00:00https://www.pembrokeconsulting.com/the-state-of-specialty-pharmacy-2017-reflections-from-asembia17-rerun/2017-09-01T11:12:58+00:00https://www.pembrokeconsulting.com/life-sciences-2nd-annual-value-based-contracting-summit/2017-09-05T11:39:45+00:00https://www.pembrokeconsulting.com/2016s-fastest-growing-private-specialty-pharmacies-from-the-inc-5000/2017-09-06T11:35:42+00:00https://www.pembrokeconsulting.com/cbis-9th-federal-pricing-and-reporting-summit-va-dod-phs/2017-09-11T11:25:57+00:00https://www.pembrokeconsulting.com/why-manufacturers-and-pbms-should-worry-about-the-growth-of-hospital-owned-specialty-pharmacies/2017-09-12T19:33:53+00:00https://www.pembrokeconsulting.com/whats-behind-the-slowdown-in-specialty-pharmacy-ma-deals/2017-09-14T11:20:34+00:00https://www.pembrokeconsulting.com/remicade-a-case-study-in-how-u-s-pricing-and-reimbursement-curb-adoption-of-biosimilars/2017-09-19T11:13:21+00:00https://www.pembrokeconsulting.com/life-sciences-aco-idn-collaboration-summit/2017-09-25T07:59:12+00:00https://www.pembrokeconsulting.com/drug-wholesalers-struggle-slower-revenue-growth-and-lower-gross-margins-for-2017/2017-09-26T05:59:35+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-september-2017-a-walgreens-rite-aid-deal-postmortem-impax-likes-amazon-health-insurance-history-and-gross-to-net-bubble-emojis/2017-09-28T11:36:22+00:00https://www.pembrokeconsulting.com/join-me-at-cbis-trade-and-channel-strategies-2017-conference/2017-10-02T11:32:27+00:00https://www.pembrokeconsulting.com/new-the-2017-18-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2017-10-03T11:41:35+00:00https://www.pembrokeconsulting.com/cbis-3rd-annual-patient-registries-summit/2017-10-10T11:16:29+00:00https://www.pembrokeconsulting.com/thanks-california-sb17-will-trigger-massive-speculative-buying-windfall-pharmacy-profits-and-supply-chain-disruption/2017-10-11T13:57:58+00:00https://www.pembrokeconsulting.com/cbis-specialty-product-data-strategies-summit/2017-10-16T11:33:20+00:00https://www.pembrokeconsulting.com/exclusive-preferred-pharmacy-networks-will-dominate-2018-medicare-part-d-plans-plus-we-review-the-top-plan-sponsors/2017-10-17T11:32:52+00:00https://www.pembrokeconsulting.com/cvs-bets-big-our-exclusive-analysis-of-pharmacy-chain-participation-in-2018s-part-d-preferred-pharmacy-networks/2017-10-19T19:07:45+00:00https://www.pembrokeconsulting.com/cbis-patient-journey-mapping-2017-conference/2017-10-23T11:38:26+00:00https://www.pembrokeconsulting.com/reality-check-new-prime-therapeutics-data-show-very-low-drug-spending-growth-in-2017/2017-10-24T13:53:23+00:00https://www.pembrokeconsulting.com/how-independent-pharmacies-will-participate-or-not-in-2018s-part-d-preferred-pharmacy-networks/2017-10-26T11:46:19+00:00https://www.pembrokeconsulting.com/cbis-drug-pricing-transparency-congress/2017-10-30T14:58:01+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-october-2017-ftc-workshop-on-pbms-hdhps-oop-spending-hospital-profits-and-fda-biosimilar-cartoons/2017-10-31T10:42:30+00:00https://www.pembrokeconsulting.com/the-latest-on-amazons-pharmacy-ambitions-and-a-possible-express-scripts-collaboration/2017-11-02T11:42:38+00:00https://www.pembrokeconsulting.com/cbis-15th-specialty-therapies-a-forum-for-payers/2017-11-06T12:40:25+00:00https://www.pembrokeconsulting.com/employer-pharmacy-benefits-in-2017-more-cost-shifting-to-patients-as-tiers-and-coinsurance-expand/2017-11-07T12:37:10+00:00https://www.pembrokeconsulting.com/shopping-for-prescriptions-how-deductibles-will-reshape-the-pharmacy-industry/2017-11-09T12:45:52+00:00https://www.pembrokeconsulting.com/drug-spending-in-2017-the-ceo-of-prime-therapeutics-responds-to-drug-channels/2017-11-10T12:40:01+00:00https://www.pembrokeconsulting.com/specialty-pharmacys-new-frontier-how-to-deliver-and-document-therapy-outcomes/2017-11-13T12:33:12+00:00https://www.pembrokeconsulting.com/if-employers-are-so-unhappy-with-their-pbms-why-cant-they-change-the-model/2017-11-15T12:41:39+00:00https://www.pembrokeconsulting.com/cbis-13th-trade-and-channel-strategies/2017-11-20T12:30:33+00:00https://www.pembrokeconsulting.com/will-cms-pop-the-gross-to-net-bubble-in-medicare-part-d-with-point-of-sale-rebates/2017-11-22T01:40:50+00:00https://www.pembrokeconsulting.com/join-me-at-the-pbmi-2018-annual-national-conference/2017-11-27T12:42:03+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-november-2017-amazons-updated-plans-premiers-push-back-diplomats-pbms-and-my-0-02-on-alex-azar/2017-11-28T12:33:17+00:00https://www.pembrokeconsulting.com/why-cvs-health-and-express-scripts-sold-and-mckesson-bought-a-specialty-hub-business/2017-11-30T19:52:30+00:00https://www.pembrokeconsulting.com/cbis-10th-hub-and-spp-model-optimization/2017-12-04T12:30:04+00:00https://www.pembrokeconsulting.com/the-cvs-aetna-deal-five-industry-and-drug-channel-implications/2017-12-05T13:19:48+00:00https://www.pembrokeconsulting.com/five-industry-trends-for-u-s-drug-wholesalers-in-2018/2017-12-07T12:44:54+00:00https://www.pembrokeconsulting.com/triplefin-how-an-independent-service-provider-is-positioning-for-growth/2017-12-08T12:28:30+00:00https://www.pembrokeconsulting.com/spcma-business-forum-2018/2017-12-11T12:32:09+00:00https://www.pembrokeconsulting.com/cms-confirms-it-drug-spending-slows-hospital-and-physician-spending-grows/2017-12-12T12:35:30+00:00https://www.pembrokeconsulting.com/2016-drug-spending-the-shift-from-employers-to-government-payers-and-troubling-trends-for-patients/2017-12-14T16:49:58+00:00https://www.pembrokeconsulting.com/life-sciences-market-access-commercialization-lsmac-summit/2017-12-15T12:31:53+00:00https://www.pembrokeconsulting.com/cbis-5th-annual-reimbursement-contracting-conference/2017-12-18T12:44:13+00:00https://www.pembrokeconsulting.com/drug-channels-outlook-what-to-watch-in-2018/2017-12-19T12:46:17+00:00https://www.pembrokeconsulting.com/follow-the-dollar-math-how-much-do-pharmacies-wholesalers-and-pbms-make-from-a-prescription-rerun/2017-12-20T12:35:07+00:00https://www.pembrokeconsulting.com/why-manufacturers-and-pbms-should-worry-about-the-growth-of-hospital-owned-specialty-pharmacies-rerun/2017-12-21T13:24:46+00:00https://www.pembrokeconsulting.com/remicade-a-case-study-in-how-u-s-pricing-and-reimbursement-curb-adoption-of-biosimilars-rerun/2017-12-22T12:35:15+00:00https://www.pembrokeconsulting.com/copay-accumulators-costly-consequences-of-a-new-cost-shifting-pharmacy-benefit/2018-01-03T19:47:44+00:00https://www.pembrokeconsulting.com/new-data-pharmacy-owners-profits-fall-as-industry-competition-rises/2018-01-09T12:31:12+00:00https://www.pembrokeconsulting.com/2026-pharmacist-job-outlook-looks-good-especially-for-hospital-pharmacists/2018-01-11T13:24:59+00:00https://www.pembrokeconsulting.com/the-life-sciences-patient-congress/2018-01-16T12:35:21+00:00https://www.pembrokeconsulting.com/employers-are-extracting-more-of-their-rebate-dollars-from-pbms/2018-01-17T12:36:10+00:00https://www.pembrokeconsulting.com/employers-are-getting-more-rebates-than-ever-but-sharing-little-with-their-employees/2018-01-18T12:44:32+00:00https://www.pembrokeconsulting.com/pap-2018-cbis-19th-annual-patient-assistance-access-programs/2018-01-22T12:30:33+00:00https://www.pembrokeconsulting.com/new-part-d-data-cvs-wins-big-in-2018s-preferred-pharmacy-networks/2018-01-23T12:25:34+00:00https://www.pembrokeconsulting.com/the-role-of-specialty-pharmacy-in-population-health-and-value-based-care/2018-01-26T23:21:16+00:00https://www.pembrokeconsulting.com/expanded-access-programs-2018/2018-01-29T12:33:17+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-january-2018-pbm-exclusions-hospital-finances-340b-updates-and-amazon/2018-01-30T12:59:32+00:00https://www.pembrokeconsulting.com/meet-the-power-buyers-driving-generic-drug-deflation/2018-02-01T12:37:25+00:00https://www.pembrokeconsulting.com/a-lesson-from-mckesson-how-specialty-pharmacy-growth-is-hurting-wholesalers/2018-02-06T21:29:58+00:00https://www.pembrokeconsulting.com/specialty-distributors-customer-mix-changes-as-physician-buy-and-bill-fades/2018-02-08T12:33:06+00:00https://www.pembrokeconsulting.com/formulary-copay-and-access-summit/2018-02-12T12:36:37+00:00https://www.pembrokeconsulting.com/new-express-scripts-data-the-drug-spending-slowdown-is-real/2018-02-13T15:39:46+00:00https://www.pembrokeconsulting.com/exclusive-express-scripts-data-most-people-have-very-low-out-of-pocket-prescription-costs/2018-02-15T12:45:14+00:00https://www.pembrokeconsulting.com/join-me-at-asembias-specialty-pharmacy-summit-2018/2018-02-20T12:27:03+00:00https://www.pembrokeconsulting.com/the-top-15-u-s-pharmacies-of-2017-market-shares-and-key-developments-for-the-biggest-companies/2018-02-21T12:37:07+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-february-2018-walgreens-boots-alliance-amerisourcebergen-copay-coupons-and-amazon/2018-02-22T13:40:34+00:00https://www.pembrokeconsulting.com/exclusive-express-scripts-data-most-people-have-very-low-out-of-pocket-prescription-costs-2/2018-02-15T12:45:14+00:00https://www.pembrokeconsulting.com/cbis-2nd-annual-drug-pricing-transparency-congress/2018-02-26T12:22:57+00:00https://www.pembrokeconsulting.com/new-the-2018-economic-report-on-u-s-pharmacies-and-pharmacy-benefit-managers/2018-02-27T12:39:48+00:00https://www.pembrokeconsulting.com/2nd-annual-manufacturers-340b-summit/2018-03-05T07:04:53+00:00https://www.pembrokeconsulting.com/as-cvs-aetna-looms-retail-pharmacy-clinic-growth-stalls/2018-03-06T07:33:12+00:00https://www.pembrokeconsulting.com/unitedhealthcares-point-of-sale-rebate-announcement-whats-next/2018-03-08T12:46:44+00:00https://www.pembrokeconsulting.com/cigna-express-scripts-vertical-integration-and-pbms-medical-pharmacy-future/2018-03-09T12:36:37+00:00https://www.pembrokeconsulting.com/2nd-annual-msl-management-development-summit/2018-03-12T11:39:43+00:00https://www.pembrokeconsulting.com/the-top-15-specialty-pharmacies-of-2017-pbms-and-payers-still-dominate/2018-03-13T11:39:52+00:00https://www.pembrokeconsulting.com/plan-sponsors-prefer-specialty-pharmacies-over-retail-drugstores/2018-03-15T12:19:17+00:00https://www.pembrokeconsulting.com/cbis-real-time-benefit-check-eprior-authorization-summit/2018-03-19T11:34:53+00:00https://www.pembrokeconsulting.com/janssens-new-transparency-report-a-peek-behind-the-drug-pricing-curtain-raises-troubling-questions-about-rebates/2018-03-20T11:39:01+00:00https://www.pembrokeconsulting.com/leveraging-technology-for-specialty-patient-engagement/2018-03-23T11:35:42+00:00https://www.pembrokeconsulting.com/cbis-5th-annual-e-rx-and-ehr-summit/2018-03-26T11:40:26+00:00https://www.pembrokeconsulting.com/five-takeaways-about-cignas-strategy-for-express-scripts/2018-03-27T11:39:47+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-march-2018-copay-accumulators-cancer-drug-costs-physician-employment-and-insurer-profits/2018-03-29T11:35:09+00:00https://www.pembrokeconsulting.com/data-rev18-summit/2018-04-02T12:03:27+00:00https://www.pembrokeconsulting.com/the-mysteries-of-pass-through-status-why-medicare-and-seniors-are-now-paying-more-for-lower-cost-biosimilars-at-hospitals/2018-04-03T18:39:40+00:00https://www.pembrokeconsulting.com/payer-power-why-eli-lilly-janssen-and-merck-deeply-discount-their-drug-prices/2018-04-05T11:44:35+00:00https://www.pembrokeconsulting.com/connect-with-drug-channels-at-asembia18/2018-04-06T11:36:44+00:00https://www.pembrokeconsulting.com/cbis-20th-annual-medicaid-and-government-pricing-congress/2018-04-09T11:35:40+00:00https://www.pembrokeconsulting.com/exclusive-a-record-number-of-specialty-pharmacies-now-have-accreditation/2018-04-10T11:38:11+00:00https://www.pembrokeconsulting.com/copay-accumulator-programs-trialcard-measures-the-impact-on-patients-and-pharmaceutical-manufacturers/2018-04-13T11:58:29+00:00https://www.pembrokeconsulting.com/cbis-4th-gpo-membership-eligibility-class-of-trade-maintenance/2018-04-16T11:38:29+00:00https://www.pembrokeconsulting.com/mckesson-leads-another-round-of-psao-consolidation/2018-04-17T11:40:17+00:00https://www.pembrokeconsulting.com/why-retail-pharmacies-still-overcharge-uninsured-patients-and-what-that-means-for-amazon/2018-04-19T11:34:22+00:00https://www.pembrokeconsulting.com/improving-patient-prescription-access-and-adherence-journeys/2018-04-20T11:45:19+00:00https://www.pembrokeconsulting.com/cbis-14th-annual-commercial-contract-chargeback-excellence/2018-04-23T11:46:33+00:00https://www.pembrokeconsulting.com/the-gross-to-net-bubble-topped-150-billion-in-2017/2018-04-24T11:38:52+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-april-2018-copay-accumulators-express-scripts-pharmacy-pricing-amazon-and-almost-pharmacist-jack-nicklaus/2018-04-26T11:35:20+00:00https://www.pembrokeconsulting.com/the-top-15-specialty-pharmacies-of-2017-pbms-and-payers-still-dominate-rerun/2018-04-30T06:11:13+00:00https://www.pembrokeconsulting.com/copay-accumulators-costly-consequences-of-a-new-cost-shifting-pharmacy-benefit-rerun/2018-05-01T05:30:10+00:00https://www.pembrokeconsulting.com/cigna-express-scripts-vertical-integration-and-pbms-medical-pharmacy-future-rerun/2018-05-02T08:44:55+00:00https://www.pembrokeconsulting.com/a-lesson-from-mckesson-how-specialty-pharmacy-growth-is-hurting-wholesalers-rerun/2018-05-03T08:13:07+00:00https://www.pembrokeconsulting.com/employers-are-getting-more-rebates-than-ever-but-sharing-little-with-their-employees-rerun/2018-05-04T11:33:19+00:00https://www.pembrokeconsulting.com/exclusive-the-340b-program-reached-19-3-billion-in-2017-as-hospitals-charity-care-has-dropped/2018-05-07T10:22:31+00:00https://www.pembrokeconsulting.com/integrate-2018-three-co-located-summits/2018-05-08T11:28:56+00:00https://www.pembrokeconsulting.com/reflections-from-asembia18-the-state-of-specialty-pharmacy-2018/2018-05-10T11:29:33+00:00https://www.pembrokeconsulting.com/the-trump-drug-pricing-plan-short-term-reprieve-long-term-disruption/2018-05-15T11:48:17+00:00https://www.pembrokeconsulting.com/cbis-reimbursement-and-access-2018/2018-05-21T11:38:48+00:00https://www.pembrokeconsulting.com/who-best-managed-the-drug-spending-slowdown-in-2017-cvs-health-express-scripts-medimpact-or-prime-therapeutics/2018-05-23T21:22:10+00:00https://www.pembrokeconsulting.com/cbis-4th-annual-specialty-pharmacy-network-design-summit/2018-05-25T11:35:16+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-may-2018-cvs-caremark-albertsonsrite-aid-copay-accumulators-and-a-world-without-pbm-rebates/2018-05-29T11:41:06+00:00https://www.pembrokeconsulting.com/the-pursuit-of-excellence-implementing-an-integrated-high-performing-specialty-pharmacy-model/2018-06-01T11:31:47+00:00https://www.pembrokeconsulting.com/cbis-4th-annual-pbm-contracting/2018-06-04T11:33:31+00:00https://www.pembrokeconsulting.com/mckessons-choppy-cs-consolidating-customers-and-challenging-contracts/2018-06-05T11:34:23+00:00https://www.pembrokeconsulting.com/hidden-policies-the-search-for-copay-accumulator-policies-in-florida-qualified-health-plans/2018-06-07T11:16:10+00:00https://www.pembrokeconsulting.com/exl-events-2nd-real-world-evidence-forum/2018-06-11T11:39:49+00:00https://www.pembrokeconsulting.com/profits-in-the-2018-fortune-500-manufacturers-vs-wholesalers-pbms-and-pharmacies/2018-06-12T11:31:39+00:00https://www.pembrokeconsulting.com/specialty-pharmacy-management-of-migraine-patients/2018-06-15T15:15:21+00:00https://www.pembrokeconsulting.com/cbis-340b-manufacturer-summit/2018-06-18T10:33:14+00:00https://www.pembrokeconsulting.com/how-walgreens-got-taken-read-this-fantastic-new-book-about-theranos/2018-06-19T11:33:20+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-june-2018-fake-news-from-ahip-azar-blasts-rebates-sanofis-pricing-asembia-in-vegas-and-justice-for-gingers/2018-06-21T12:27:28+00:00https://www.pembrokeconsulting.com/cbis-biopharma-forum-on-the-state-of-medicare-reform/2018-06-25T11:30:58+00:00https://www.pembrokeconsulting.com/the-gross-to-net-bubble-topped-150-billion-in-2017-rerun/2018-06-26T10:47:59+00:00https://www.pembrokeconsulting.com/meet-the-power-buyers-driving-generic-drug-deflation-rerun/2018-06-27T11:14:23+00:00https://www.pembrokeconsulting.com/why-retail-pharmacies-still-overcharge-uninsured-patients-and-what-that-means-for-amazon-rerun/2018-06-28T11:08:53+00:00https://www.pembrokeconsulting.com/amazon-buys-pillpack-six-pharmacy-and-drug-channel-implications/2018-06-29T11:39:53+00:00https://www.pembrokeconsulting.com/cbis-4th-annual-compliance-congress-for-specialty-products/2018-07-02T11:36:15+00:00https://www.pembrokeconsulting.com/democrats-and-republicans-agree-drug-channels-is-awesome/2018-07-03T13:37:08+00:00https://www.pembrokeconsulting.com/2nd-annual-pharma-digital-marketing-multichannel-integration-summit/2018-07-09T11:35:07+00:00https://www.pembrokeconsulting.com/gao-confirms-it-340b-hospitals-and-contract-pharmacies-profit-from-low-income-uninsured-patients/2018-07-10T11:33:05+00:00https://www.pembrokeconsulting.com/our-exclusive-analysis-nearly-one-in-three-u-s-pharmacies-is-a-340b-contract-pharmacy-five-chains-dominate/2018-07-12T10:03:31+00:00https://www.pembrokeconsulting.com/the-trump-administrations-blueprint-a-preview-of-the-23rd-annual-mdrp-summit/2018-07-13T11:37:36+00:00https://www.pembrokeconsulting.com/cbis-6th-annual-coupon-and-copay-summit/2018-07-16T11:34:43+00:00https://www.pembrokeconsulting.com/specialty-pharmacies-and-pbms-penetrate-the-340b-program-and-how-manufacturers-should-respond/2018-07-18T11:34:06+00:00https://www.pembrokeconsulting.com/cbis-11th-hub-and-spp-model-optimization/2018-07-23T11:38:39+00:00https://www.pembrokeconsulting.com/building-a-new-drug-wholesaler-compensation-model-what-happens-as-brand-inflation-slows/2018-07-24T11:21:46+00:00https://www.pembrokeconsulting.com/cbis-pap-legal-update-forum/2018-07-30T11:34:04+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-july-2018-amazons-med-surg-business-naughty-340b-hospitals-goodrx-pricing-data-and-cvss-musical-controversy/2018-07-31T11:33:34+00:00https://www.pembrokeconsulting.com/a-system-without-rebates-the-drug-channels-negotiated-discounts-model/2018-08-02T11:43:23+00:00https://www.pembrokeconsulting.com/cbis-west-coast-real-time-benefit-check-eprior-authorization-summit/2018-08-06T11:32:55+00:00https://www.pembrokeconsulting.com/still-possible-hospitals-overcharge-health-plans-for-specialty-drugs/2018-08-08T11:38:13+00:00https://www.pembrokeconsulting.com/redefining-digital-health-how-a-different-approach-can-get-manufacturers-closer-to-patients/2018-08-10T14:47:37+00:00https://www.pembrokeconsulting.com/new-disclosures-show-cvs-and-express-scripts-can-survive-in-a-world-without-rebates-are-plan-sponsors-now-the-real-barrier-to-disruption/2018-08-14T11:33:26+00:00https://www.pembrokeconsulting.com/2019-express-scripts-formulary-exclusions-hepatitis-c-changes-show-why-the-drug-channel-must-change-too/2018-08-16T15:05:55+00:00https://www.pembrokeconsulting.com/cbis-13th-annual-value-based-oncology-management-summit/2018-08-20T11:30:40+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-august-2018-pbm-spread-profits-part-d-rebates-340b-questions-amazon-and-dentists-and-pbs-on-pbms/2018-08-21T11:32:25+00:00https://www.pembrokeconsulting.com/cbis-3rd-edition-drug-pricing-transparency-congress/2018-08-27T11:32:10+00:00https://www.pembrokeconsulting.com/profits-in-the-2018-fortune-500-manufacturers-vs-wholesalers-pbms-and-pharmacies-rerun/2018-08-28T11:36:43+00:00https://www.pembrokeconsulting.com/who-best-managed-the-drug-spending-slowdown-in-2017-cvs-health-express-scripts-medimpact-or-prime-therapeutics-rerun/2018-08-29T11:33:42+00:00https://www.pembrokeconsulting.com/exclusive-the-340b-program-reached-19-3-billion-in-2017-as-hospitals-charity-care-has-dropped-rerun/2018-08-30T11:34:17+00:00https://www.pembrokeconsulting.com/the-state-of-specialty-pharmacy-2018-reflections-from-asembia18-rerun/2018-08-31T11:08:52+00:00https://www.pembrokeconsulting.com/3rd-annual-life-sciences-value-based-contracting/2018-09-04T11:33:41+00:00https://www.pembrokeconsulting.com/how-2017s-fastest-growing-private-specialty-pharmacies-highlight-an-industry-slowdown/2018-09-05T11:35:30+00:00https://www.pembrokeconsulting.com/the-medical-affairs-launch-strategy-summit/2018-09-10T11:39:47+00:00https://www.pembrokeconsulting.com/updated-part-b-data-hospitals-are-displacing-physician-offices-even-faster-than-we-thought/2018-09-12T11:31:15+00:00https://www.pembrokeconsulting.com/artificial-intelligence-ai-how-specialty-pharmacies-are-making-medication-package-management-more-predictable-scalable-and-efficient/2018-09-14T11:46:49+00:00https://www.pembrokeconsulting.com/gtn-2018-cbis-gross-to-net-summit/2018-09-17T11:37:11+00:00https://www.pembrokeconsulting.com/copay-accumulator-update-widespread-adoption-as-manufacturers-and-maximizers-limit-patient-impact/2018-09-18T11:42:08+00:00https://www.pembrokeconsulting.com/preorder-now-our-2018-19-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2018-09-20T11:35:51+00:00https://www.pembrokeconsulting.com/its-time-to-rethink-channel-strategy-for-oral-oncolytics/2018-09-21T11:43:10+00:00https://www.pembrokeconsulting.com/cbis-10th-federal-pricing-and-reporting-va-dod-phs/2018-09-24T11:37:32+00:00https://www.pembrokeconsulting.com/the-cigna-express-scripts-deals-intriguing-connections-with-and-implications-for-amerisourcebergen-and-walgreens/2018-09-25T11:47:23+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-september-2018-gileads-price-cuts-out-of-pocket-costs-hospital-physician-vertical-integration-and-wxpn-me/2018-09-27T11:37:11+00:00https://www.pembrokeconsulting.com/therigys-free-webinar-systems-interoperability-and-its-impact-on-coordinated-specialty-therapy-management/2018-10-01T11:42:31+00:00https://www.pembrokeconsulting.com/does-rite-aid-have-the-grit-to-succeed-with-its-envisionrx-pbm-business/2018-10-03T11:33:06+00:00https://www.pembrokeconsulting.com/cbis-copay-accumulator-summit/2018-10-08T11:35:08+00:00https://www.pembrokeconsulting.com/new-the-2018-19-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2018-10-09T20:44:33+00:00https://www.pembrokeconsulting.com/dir-fees-a-prescription-while-you-wait/2018-10-12T11:51:11+00:00https://www.pembrokeconsulting.com/join-me-at-cbis-14th-life-sciences-trade-and-channel-strategies/2018-10-15T11:37:22+00:00https://www.pembrokeconsulting.com/exclusive-humana-triggers-a-small-pullback-for-preferred-pharmacy-networks-in-2019-medicare-part-d-plus-top-sponsors-and-cvs-healths-pos-plan/2018-10-16T11:42:17+00:00https://www.pembrokeconsulting.com/battle-royale-cvs-and-kroger-gain-walgreens-slips-in-2019-part-d-preferred-pharmacy-networks/2018-10-18T11:39:58+00:00https://www.pembrokeconsulting.com/mckesson-biopharma-companies-need-an-integrated-customized-and-high-touch-approach-to-solve-critical-commercialization-challenges/2018-10-19T11:42:17+00:00https://www.pembrokeconsulting.com/the-law-of-holes-some-independents-skip-2019-part-d-preferred-pharmacy-networks/2018-10-23T11:36:21+00:00https://www.pembrokeconsulting.com/pbm-pricing-overhaul-express-scripts-prepares-for-a-world-without-rebates-but-employers-may-not-change/2018-10-25T17:25:14+00:00https://www.pembrokeconsulting.com/cbis-6th-annual-reimbursement-contracting-conference/2018-10-29T11:34:34+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-october-2018-amgen-walgreens-rite-aids-pbm-drug-price-ads-and-buy-and-bill-murray/2018-10-30T19:23:53+00:00https://www.pembrokeconsulting.com/surprise-deal-cardinal-health-sells-its-specialty-pharmacy-again/2018-11-01T13:10:23+00:00https://www.pembrokeconsulting.com/cbis-specialty-therapies-2019/2018-11-05T12:32:16+00:00https://www.pembrokeconsulting.com/employer-pharmacy-benefits-in-2018-more-tiers-greater-coinsurance-and-lots-of-high-deductible-plans/2018-11-06T12:23:42+00:00https://www.pembrokeconsulting.com/drug-prices-after-the-midterms-five-crucial-implications-of-pharmacy-benefit-design/2018-11-08T09:31:54+00:00https://www.pembrokeconsulting.com/enhancing-care-for-and-management-of-hepatitis-c-patients/2018-11-09T11:26:42+00:00https://www.pembrokeconsulting.com/13th-annual-health-care-supply-chain-summit/2018-11-13T11:33:57+00:00https://www.pembrokeconsulting.com/express-scripts-launches-a-new-formulary-for-a-world-without-rebates-will-plan-sponsors-and-drug-makers-play-along/2018-11-14T12:32:13+00:00https://www.pembrokeconsulting.com/commercializing-cell-and-gene-therapies-with-high-touch-services/2018-11-16T12:52:26+00:00https://www.pembrokeconsulting.com/cbis-14th-life-sciences-trade-and-channel-strategies/2018-11-19T08:18:18+00:00https://www.pembrokeconsulting.com/cbis-12th-hub-and-spp-model-optimization/2018-11-26T12:37:50+00:00https://www.pembrokeconsulting.com/pharmacist-salaries-keep-rising-hospitals-continue-to-lead-in-wage-and-employment-growth/2018-11-27T12:31:35+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-november-2018-amazonpillpack-update-fake-news-from-bcbsa-drug-list-prices-in-ads-part-d-plans-and-dan-best/2018-11-29T11:35:26+00:00https://www.pembrokeconsulting.com/the-ndc-shortage-what-the-fda-could-and-should-do-to-address-it/2018-11-30T16:29:46+00:00https://www.pembrokeconsulting.com/pbmi-2019-annual-national-conference/2018-12-03T12:45:24+00:00https://www.pembrokeconsulting.com/cms-considers-point-of-sale-pharmacy-dir-another-prelude-to-a-world-without-rebates/2018-12-04T12:40:30+00:00https://www.pembrokeconsulting.com/five-industry-trends-for-u-s-drug-wholesalers-in-2019/2018-12-06T12:34:48+00:00https://www.pembrokeconsulting.com/delivering-care-beyond-prescriptions-a-marketplace-opportunity-for-independent-pharmacies/2018-12-07T12:49:38+00:00https://www.pembrokeconsulting.com/spcma-business-forum/2018-12-10T12:38:58+00:00https://www.pembrokeconsulting.com/cms-confirms-it-again-minimal-drug-spending-growth-while-hospital-and-physician-spending-keep-going/2018-12-11T12:08:10+00:00https://www.pembrokeconsulting.com/drug-channels-outlook-what-to-watch-in-2019/2018-12-13T15:50:45+00:00https://www.pembrokeconsulting.com/three-reasons-to-join-the-industry-wide-effort-to-speed-time-to-therapy-for-specialty-pharmacy/2018-12-14T12:48:33+00:00https://www.pembrokeconsulting.com/copay-accumulator-update-widespread-adoption-as-manufacturers-and-maximizers-limit-patient-impact-rerun/2018-12-17T12:35:10+00:00https://www.pembrokeconsulting.com/gao-confirms-it-340b-hospitals-and-contract-pharmacies-profit-from-low-income-uninsured-patients-rerun/2018-12-18T12:46:19+00:00https://www.pembrokeconsulting.com/building-a-new-drug-wholesaler-compensation-model-what-happens-as-brand-inflation-slows-rerun/2018-12-19T12:22:24+00:00https://www.pembrokeconsulting.com/new-disclosures-show-cvs-and-express-scripts-can-survive-in-a-world-without-rebates-are-plan-sponsors-now-the-real-barrier-to-disruption-rerun/2018-12-20T12:34:19+00:00https://www.pembrokeconsulting.com/a-system-without-rebates-the-drug-channels-negotiated-discounts-model-rerun/2018-12-21T11:57:32+00:00https://www.pembrokeconsulting.com/specialty-pharmacy-ma-our-look-at-2018s-deals/2019-01-03T12:40:24+00:00https://www.pembrokeconsulting.com/cbis-20th-annual-patient-assistance-access-programs-pap-2019/2019-01-07T12:32:10+00:00https://www.pembrokeconsulting.com/the-big-three-generic-drug-mega-buyers-drove-double-digit-deflation-in-2018-stability-ahead/2019-01-08T12:38:35+00:00https://www.pembrokeconsulting.com/cbis-6th-annual-e-rx-and-ehr/2019-01-14T09:28:33+00:00https://www.pembrokeconsulting.com/independent-pharmacy-economics-keep-deteriorating/2019-01-15T11:04:48+00:00https://www.pembrokeconsulting.com/cbis-15th-annual-life-sciences-accounting-reporting-congress/2019-01-22T12:31:05+00:00https://www.pembrokeconsulting.com/new-part-d-enrollment-data-cvs-extends-its-lead-in-2019-preferred-pharmacy-networks/2019-01-23T12:32:11+00:00https://www.pembrokeconsulting.com/drug-prices-are-not-skyrocketing-theyre-barely-growing-at-all/2019-01-29T12:55:12+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-january-2019-part-d-plan-profits-hospitals-vs-drugs-and-bs-in-healthcare/2019-01-31T12:28:55+00:00https://www.pembrokeconsulting.com/shaping-an-effective-data-and-analytics-strategy-for-your-oncology-therapy-in-2019/2019-02-01T12:46:42+00:00https://www.pembrokeconsulting.com/partnering-with-idns-biopharma-strategy-summit-west/2019-02-04T12:31:09+00:00https://www.pembrokeconsulting.com/my-wall-street-journal-op-ed-dont-blame-drug-prices-on-big-pharma/2019-02-05T12:40:52+00:00https://www.pembrokeconsulting.com/expanded-access-programs-2019/2019-02-11T12:37:17+00:00https://www.pembrokeconsulting.com/express-scripts-confirms-it-again-minimal-growth-in-drug-spending-and-prescription-costs/2019-02-12T12:37:49+00:00https://www.pembrokeconsulting.com/preorder-now-our-2019-economic-report-on-u-s-pharmacies-and-pharmacy-benefit-managers/2019-02-14T12:43:41+00:00https://www.pembrokeconsulting.com/pharmacy-fraud-within-pharmaceutical-co-pay-programs-what-you-need-to-know/2019-02-15T12:55:28+00:00https://www.pembrokeconsulting.com/cbis-4th-edition-drug-pricing-transparency-congress/2019-02-19T12:32:25+00:00https://www.pembrokeconsulting.com/how-health-plans-profit-and-patients-lose-from-highly-rebated-brand-name-drugs/2019-02-20T12:47:00+00:00https://www.pembrokeconsulting.com/cbis-5th-annual-formulary-copay-and-access-summit/2019-02-25T12:31:24+00:00https://www.pembrokeconsulting.com/the-top-15-u-s-pharmacies-of-2018-ma-reshapes-the-market/2019-02-26T12:35:17+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-february-2019-diplomats-troubles-sanofis-gross-to-net-bubble-and-the-legality-of-accumulators/2019-02-28T11:28:46+00:00https://www.pembrokeconsulting.com/join-me-for-asembias-specialty-pharmacy-summit-2019/2019-03-04T12:33:00+00:00https://www.pembrokeconsulting.com/new-the-2019-economic-report-on-u-s-pharmacies-and-pharmacy-benefit-managers/2019-03-05T12:33:27+00:00https://www.pembrokeconsulting.com/delivering-an-enhanced-patient-and-prescriber-experience-for-personalized-therapies/2019-03-08T12:39:47+00:00https://www.pembrokeconsulting.com/3rd-annual-manufacturers-340b-summit/2019-03-11T11:32:31+00:00https://www.pembrokeconsulting.com/employers-are-absorbing-even-more-manufacturer-rebates-from-their-pbms/2019-03-12T11:33:54+00:00https://www.pembrokeconsulting.com/a-world-without-rebates-predictions-for-how-the-channel-will-evolve-and-why-drug-prices-will-go-down/2019-03-20T11:35:47+00:00https://www.pembrokeconsulting.com/cbis-21st-annual-medicaid-and-government-pricing-congress/2019-03-25T11:37:57+00:00https://www.pembrokeconsulting.com/latest-cms-forecast-hospitals-and-physicians-will-grab-most-of-the-1-3-trillion-increase-in-u-s-healthcare-spending/2019-03-26T15:44:54+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-march-2019-the-insulin-gross-to-net-bubble-hhs-blasts-rebates-a-new-340b-report-and-theranos/2019-03-28T18:21:01+00:00https://www.pembrokeconsulting.com/the-gross-to-net-bubble-reached-a-record-166-billion-in-2018/2019-04-03T11:34:23+00:00https://www.pembrokeconsulting.com/addressing-the-rising-impact-of-co-pay-accumulators-on-patients/2019-04-05T11:26:46+00:00https://www.pembrokeconsulting.com/world-congress-integrate-2019/2019-04-08T11:34:21+00:00https://www.pembrokeconsulting.com/the-top-15-specialty-pharmacies-of-2018-pbms-keep-winning/2019-04-09T11:42:35+00:00https://www.pembrokeconsulting.com/preparing-for-a-world-without-rebates-a-drug-channels-institute-webinar/2019-04-10T12:18:59+00:00https://www.pembrokeconsulting.com/drug-price-transparency-and-rebate-reform-take-center-stage/2019-04-12T11:51:19+00:00https://www.pembrokeconsulting.com/rare-disease-innovation-and-partnering-summit/2019-04-15T11:34:09+00:00https://www.pembrokeconsulting.com/the-road-to-2020-understanding-the-regulatory-timeline-for-part-d-rebate-reform/2019-04-16T11:41:22+00:00https://www.pembrokeconsulting.com/trialcard-the-role-of-hub-services-in-an-era-of-drug-price-transparency-value-based-care-and-consumerism/2019-04-19T01:07:00+00:00https://www.pembrokeconsulting.com/cbis-15th-annual-commercial-contract-chargeback-excellence/2019-04-22T12:04:27+00:00https://www.pembrokeconsulting.com/the-specialty-pharmacy-boom-our-exclusive-update-on-the-u-s-market/2019-04-23T11:58:24+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-april-2019-cignas-insulin-program-amazons-pillpack-moves-magellans-biosimilar-success-primes-formulary-exclusions-and-a-world-without/2019-04-25T11:36:47+00:00https://www.pembrokeconsulting.com/help-for-the-patient-journey-electronic-modernization-of-medication-access/2019-04-26T13:50:17+00:00https://www.pembrokeconsulting.com/financial-strategies-and-accounting-for-bioscience-companies/2019-04-29T05:45:07+00:00https://www.pembrokeconsulting.com/my-wall-street-journal-op-ed-dont-blame-drug-prices-on-big-pharma-rerun/2019-04-30T06:46:23+00:00https://www.pembrokeconsulting.com/express-scripts-launches-a-new-formulary-for-a-world-without-rebates-will-plan-sponsors-and-drug-makers-play-along-rerun/2019-05-01T05:28:43+00:00https://www.pembrokeconsulting.com/independent-pharmacy-economics-keep-deteriorating-rerun/2019-05-02T09:41:00+00:00https://www.pembrokeconsulting.com/specialty-pharmacy-ma-our-look-at-2018s-deals-rerun/2019-05-03T06:00:07+00:00https://www.pembrokeconsulting.com/patient-support-services-congress/2019-05-06T11:33:42+00:00https://www.pembrokeconsulting.com/the-state-of-specialty-pharmacy-2019-industry-trends-and-photos-from-asembia19/2019-05-07T11:37:59+00:00https://www.pembrokeconsulting.com/cbis-strategic-medicare-contracting-forum-for-biopharmaceutical-manufacturers/2019-05-13T11:37:22+00:00https://www.pembrokeconsulting.com/exclusive-340b-program-purchases-reach-24-3-billion-7-of-the-pharma-market-as-hospitals-charity-care-flatlines/2019-05-14T11:31:58+00:00https://www.pembrokeconsulting.com/340b-health-gets-it-wrong-again/2019-05-16T12:28:22+00:00https://www.pembrokeconsulting.com/a-new-starting-point-for-patient-support-technology-driven-hub-services/2019-05-17T11:56:45+00:00https://www.pembrokeconsulting.com/reimbursement-and-access-2019/2019-05-20T11:31:16+00:00https://www.pembrokeconsulting.com/which-pbm-best-managed-drug-spending-in-2018-cvs-health-express-scripts-medimpact-or-prime-therapeutics/2019-05-22T13:44:23+00:00https://www.pembrokeconsulting.com/partnering-with-idns-biopharma-strategy-summit-east/2019-05-28T11:34:13+00:00https://www.pembrokeconsulting.com/cvs-express-scripts-and-the-evolution-of-the-pbm-business-model/2019-05-29T11:33:11+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-may-2019-express-scripts-new-gpo-more-on-amazonpillpack-a-bs-update-and-vegas-video/2019-05-30T11:34:18+00:00https://www.pembrokeconsulting.com/medicaid-drug-rebate-program-summit-2019/2019-06-03T11:33:54+00:00https://www.pembrokeconsulting.com/profits-in-the-2019-fortune-500-manufacturers-vs-managed-care-vs-pharmacies-pbms-and-wholesalers/2019-06-05T11:25:08+00:00https://www.pembrokeconsulting.com/cbis-reimbursement-and-access-2019/2019-06-10T11:31:45+00:00https://www.pembrokeconsulting.com/cvs-health-will-this-giants-scale-and-scope-confound-its-vision-for-healthcare/2019-06-12T11:35:40+00:00https://www.pembrokeconsulting.com/pbm-contracting-2019/2019-06-17T11:30:26+00:00https://www.pembrokeconsulting.com/meet-the-top-ten-drugs-of-2024-maybe/2019-06-18T11:27:07+00:00https://www.pembrokeconsulting.com/new-340b-health-reports-confirms-the-programs-size-but-double-dips-on-hospitals-community-benefit-obligations/2019-06-20T11:28:15+00:00https://www.pembrokeconsulting.com/cbis-5th-annual-340b-manufacturer-summit/2019-06-24T11:50:34+00:00https://www.pembrokeconsulting.com/a-cvs-lawsuit-uncovers-three-surprising-revelations-about-amazons-pillpack-strategy/2019-06-25T11:31:39+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-june-2019-pbm-spread-pricing-rebate-walls-reforming-part-d-and-not-so-smart-bulbs/2019-06-27T11:30:11+00:00https://www.pembrokeconsulting.com/national-association-of-specialty-pharmacy-7th-annual-meeting-and-expo/2019-07-01T11:32:06+00:00https://www.pembrokeconsulting.com/pbmis-2019-specialty-rx-forum/2019-07-08T11:33:25+00:00https://www.pembrokeconsulting.com/the-big-three-generic-drug-mega-buyers-drove-double-digit-deflation-in-2018-stability-ahead-rerun/2019-07-09T11:59:26+00:00https://www.pembrokeconsulting.com/how-health-plans-profit-and-patients-lose-from-highly-rebated-brand-name-drugs-rerun/2019-07-10T11:38:14+00:00https://www.pembrokeconsulting.com/the-gross-to-net-bubble-reached-a-record-166-billion-in-2018-rerun/2019-07-11T18:34:55+00:00https://www.pembrokeconsulting.com/six-reasons-why-the-rebate-rule-failed-and-whats-next/2019-07-12T11:48:57+00:00https://www.pembrokeconsulting.com/cbis-3rd-annual-finance-account-for-bioscience-companies/2019-07-15T11:33:12+00:00https://www.pembrokeconsulting.com/jama-withdraw-this-flawed-and-inaccurate-article-about-the-340b-program-and-drug-prices/2019-07-16T11:04:36+00:00https://www.pembrokeconsulting.com/walgreens-cvs-and-walmart-lead-the-25000-pharmacies-now-profiting-from-the-340b-program/2019-07-18T11:35:11+00:00https://www.pembrokeconsulting.com/expanding-patient-engagement-in-commercial-healthcare/2019-07-19T11:36:37+00:00https://www.pembrokeconsulting.com/cbis-13th-hub-and-spp-model-optimization/2019-07-22T11:36:20+00:00https://www.pembrokeconsulting.com/our-stat-op-ed-drug-importation-cant-coexist-with-u-s-track-and-trace-law/2019-07-23T11:31:03+00:00https://www.pembrokeconsulting.com/improving-medication-access-through-network-connections-to-impact-more-patients/2019-07-26T11:45:25+00:00https://www.pembrokeconsulting.com/cbis-5th-annual-life-sciences-compliance-congress-for-specialty-products/2019-07-29T13:18:15+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-july-2019-amazonpillpack-novo-nordisk-on-the-g2n-bubble-copay-accumulators-and-adams-favorite-chart/2019-07-30T11:33:32+00:00https://www.pembrokeconsulting.com/specialty-pharmacies-and-pbms-hop-on-the-340b-money-train/2019-08-01T11:31:57+00:00https://www.pembrokeconsulting.com/cbis-7th-annual-coupon-and-copay-forum/2019-08-05T11:33:58+00:00https://www.pembrokeconsulting.com/heres-how-pbms-and-specialty-pharmacies-snag-super-size-profits-from-the-340b-program/2019-08-07T11:29:13+00:00https://www.pembrokeconsulting.com/as-hospitals-pursue-specialty-pharmacy-and-walgreens-bets-more-on-340b-pbms-become-their-best-frenemies/2019-08-14T11:44:00+00:00https://www.pembrokeconsulting.com/cbis-5th-edition-drug-pricing-transparency-congress/2019-08-15T11:30:01+00:00https://www.pembrokeconsulting.com/cbis-14th-annual-value-based-oncology-management-summit/2019-08-19T04:00:08+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-august-2019-amazon-insanity-diplomats-final-days-express-scripts-dir-fees-exposed-and-a-rebate-cartoon/2019-08-20T04:24:16+00:00https://www.pembrokeconsulting.com/decreasing-prescription-abandonment-with-price-transparency/2019-08-23T11:22:13+00:00https://www.pembrokeconsulting.com/which-pbm-best-managed-drug-spending-in-2018-cvs-health-express-scripts-medimpact-or-prime-therapeutics-rerun/2019-08-26T11:53:18+00:00https://www.pembrokeconsulting.com/profits-in-the-2019-fortune-500-manufacturers-vs-managed-care-vs-pharmacies-pbms-and-wholesalers-rerun/2019-08-27T11:33:22+00:00https://www.pembrokeconsulting.com/the-state-of-specialty-pharmacy-2019-industry-trends-and-photos-from-asembia19-rerun/2019-08-28T11:31:02+00:00https://www.pembrokeconsulting.com/cvs-express-scripts-and-the-evolution-of-the-pbm-business-model-rerun/2019-08-29T11:17:51+00:00https://www.pembrokeconsulting.com/340b-program-purchases-reach-24-3-billion-7-of-the-pharma-market-as-hospitals-charity-care-flatlines-rerun/2019-08-30T11:14:31+00:00https://www.pembrokeconsulting.com/cbis-4th-annual-outcomes-based-agreements-innovative-payer-contracting-summit/2019-09-03T11:20:48+00:00https://www.pembrokeconsulting.com/the-shakeout-begins-the-fastest-growing-private-specialty-pharmacies-of-2018/2019-09-04T12:08:44+00:00https://www.pembrokeconsulting.com/preorder-now-our-2019-20-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2019-09-05T11:19:35+00:00https://www.pembrokeconsulting.com/cbis-federal-pricing-and-reporting/2019-09-09T11:49:40+00:00https://www.pembrokeconsulting.com/we-shouldnt-give-up-on-biosimilars-and-here-are-the-data-to-prove-it/2019-09-10T14:06:11+00:00https://www.pembrokeconsulting.com/cbis-gross-to-net-summit-gtn-2019/2019-09-16T11:03:03+00:00https://www.pembrokeconsulting.com/half-off-sale-five-major-drugmakers-reveal-vast-gross-to-net-price-gaps-and-why-rebate-reform-is-still-needed/2019-09-17T14:26:05+00:00https://www.pembrokeconsulting.com/employers-slowly-warm-to-point-of-sale-rebates-but-must-move-faster-for-insulin/2019-09-19T17:30:49+00:00https://www.pembrokeconsulting.com/cbis-strategic-medicare-contracting-forum/2019-09-23T11:09:45+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-september-2019-amazon-340b-unitedhealthcare-vs-hospitals-a-naughty-340b-hospital-generic-drug-prices-and-hotels/2019-09-25T11:00:29+00:00https://www.pembrokeconsulting.com/cbis-contracts-chargebacks-critical-update-summit/2019-10-01T11:13:09+00:00https://www.pembrokeconsulting.com/the-big-three-wholesalers-revenues-and-channel-share-up-profits-down/2019-10-02T11:18:11+00:00https://www.pembrokeconsulting.com/cbis-3rd-nurse-educator-programs/2019-10-07T11:11:15+00:00https://www.pembrokeconsulting.com/new-the-2019-20-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2019-10-08T11:50:59+00:00https://www.pembrokeconsulting.com/how-express-scripts-plans-to-disrupt-the-emerging-cell-and-gene-therapy-channel/2019-10-10T11:19:56+00:00https://www.pembrokeconsulting.com/patients-are-the-key-to-understanding-adherence/2019-10-11T11:37:47+00:00https://www.pembrokeconsulting.com/join-me-at-cbis-15th-annual-life-sciences-trade-and-channel-strategies/2019-10-14T11:17:09+00:00https://www.pembrokeconsulting.com/pharmacist-job-market-salaries-keep-growing-while-retail-employment-drops/2019-10-15T11:25:53+00:00https://www.pembrokeconsulting.com/grim-job-outlook-for-retail-pharmacists-gets-even-grimmer/2019-10-17T11:19:58+00:00https://www.pembrokeconsulting.com/how-technology-will-drive-the-future-of-patient-access-services/2019-10-18T11:32:00+00:00https://www.pembrokeconsulting.com/cbis-fdacms-summit-2019/2019-10-21T11:21:35+00:00https://www.pembrokeconsulting.com/preferred-pharmacy-networks-rebound-in-2020-medicare-part-d-plans-details-on-wellcare-cvs-health-humana-cigna-and-more/2019-10-22T11:20:33+00:00https://www.pembrokeconsulting.com/winning-cvs-kroger-and-walmart-expand-in-2020-part-d-preferred-pharmacy-networks/2019-10-24T11:28:13+00:00https://www.pembrokeconsulting.com/cbis-specialty-therapies-and-biosimilars-congress/2019-10-28T11:31:16+00:00https://www.pembrokeconsulting.com/even-more-independents-avoid-2020-part-d-preferred-pharmacy-networks/2019-10-29T15:16:56+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-october-2019-express-scripts-340b-government-negotiation-compounding-pharmacies-and-red-meat-with-onion/2019-10-31T11:42:54+00:00https://www.pembrokeconsulting.com/connecting-providers-and-technology-improving-the-patient-journey-through-actionable-insights/2019-11-01T11:18:14+00:00https://www.pembrokeconsulting.com/cvs-healths-specialty-gain-is-mckessons-pain/2019-11-05T05:48:45+00:00https://www.pembrokeconsulting.com/pharmaceutical-drug-pricing-strategies-and-copay-summits/2019-11-04T12:40:46+00:00https://www.pembrokeconsulting.com/a-tale-of-two-chains-walgreens-exits-pharmacy-clinics-while-cvs-reinvents-in-store-care/2019-11-07T07:26:28+00:00https://www.pembrokeconsulting.com/cbis-medicare-pricing-contracting-congress/2019-11-12T12:18:15+00:00https://www.pembrokeconsulting.com/employer-pharmacy-benefits-in-2019-high-deductibles-and-greater-coinsurance-expose-even-more-patients-to-prescription-list-prices/2019-11-13T12:37:05+00:00https://www.pembrokeconsulting.com/drug-channels-outlook-what-you-need-to-watch-in-2020-a-drug-channels-institute-live-webinar/2019-11-15T12:33:46+00:00https://www.pembrokeconsulting.com/cbis-15th-annual-life-sciences-trade-and-channel-strategies/2019-11-18T12:54:50+00:00https://www.pembrokeconsulting.com/part-b-update-hospitals-displacing-physicians-amid-slow-growth-in-drug-prices/2019-11-19T12:42:15+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-november-2019-amazon-pharmacy-jama-340b-redux-diplomat-hospital-physician-integration-and-the-fda/2019-11-21T12:36:00+00:00https://www.pembrokeconsulting.com/cbis-patient-registries-real-world-evidence-and-heor/2019-11-25T12:22:53+00:00https://www.pembrokeconsulting.com/pap-2020-21st-annual-patient-assistance-access-programs/2019-12-02T12:24:21+00:00https://www.pembrokeconsulting.com/the-state-of-retail-pharmacy-independent-pharmacy-economics-stabilize-but-dropping-owner-salaries-are/2019-12-03T12:48:55+00:00https://www.pembrokeconsulting.com/has-physician-specialty-dispensing-peaked-and-should-they-blame-pbms/2019-12-05T12:42:51+00:00https://www.pembrokeconsulting.com/spcma-business-forum-2020/2019-12-09T12:32:49+00:00https://www.pembrokeconsulting.com/latest-cms-data-drug-spending-is-not-skyrocketing-hospitals-and-physicians-dominate-healthcare-costs/2019-12-10T12:35:24+00:00https://www.pembrokeconsulting.com/insurers-pbms-specialty-pharmacies-providers-will-vertical-consolidation-disrupt-drug-channels-in-2020/2019-12-12T12:44:11+00:00https://www.pembrokeconsulting.com/cbis-14th-hubs-and-spp-model-optimization-summit/2019-12-16T12:40:27+00:00https://www.pembrokeconsulting.com/heres-how-pbms-and-specialty-pharmacies-snag-super-size-profits-from-the-340b-program-rerun/2019-12-17T12:40:39+00:00https://www.pembrokeconsulting.com/a-cvs-lawsuit-uncovers-three-surprising-revelations-about-amazons-pillpack-strategy-rerun/2019-12-18T12:39:06+00:00https://www.pembrokeconsulting.com/how-express-scripts-plans-to-disrupt-the-emerging-cell-and-gene-therapy-channel-rerun/2019-12-20T12:43:38+00:00https://www.pembrokeconsulting.com/cbis-16th-annual-life-sciences-accounting-reporting-congress/2020-01-06T05:00:02+00:00https://www.pembrokeconsulting.com/express-scripts-prime-therapeutics-our-four-takeaways-from-this-market-changing-deal/2020-01-07T15:09:09+00:00https://www.pembrokeconsulting.com/surprise-brand-name-drug-prices-fell-in-2019/2020-01-09T13:07:05+00:00https://www.pembrokeconsulting.com/pbmis-25th-annual-national-conference/2020-01-13T12:29:07+00:00https://www.pembrokeconsulting.com/express-scripts-vs-cvs-health-five-lessons-from-the-2020-formulary-exclusions-and-some-thoughts-on-patient-impact/2020-01-14T12:37:16+00:00https://www.pembrokeconsulting.com/why-part-d-plans-prefer-high-list-price-drugs-that-raise-costs-for-seniors/2020-01-22T12:45:37+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-january-2020-esiwalgreens-breakup-amazon-pharmacy-humiras-g2n-generic-prices-abcs-ceo-and-miss-america/2020-01-28T12:45:41+00:00https://www.pembrokeconsulting.com/the-world-congress-8th-annual-patient-congress/2020-02-03T11:40:13+00:00https://www.pembrokeconsulting.com/new-part-d-enrollment-data-for-2020-preferred-pharmacy-networks-cvs-holds-steady-walmart-rebounds-and-walgreens-tanks/2020-02-04T23:26:03+00:00https://www.pembrokeconsulting.com/informa-connect-cbis-6th-edition-drug-pricing-transparency-congress/2020-02-10T11:44:12+00:00https://www.pembrokeconsulting.com/preorder-now-the-2020-economic-report-on-u-s-pharmacies-and-pharmacy-benefit-managers/2020-02-11T12:28:08+00:00https://www.pembrokeconsulting.com/pharmacy-dir-fees-hit-a-record-9-billion-in-2019-thats-18-of-total-medicare-part-d-rebates/2020-02-13T12:11:43+00:00https://www.pembrokeconsulting.com/informa-connect-cbis-formulary-and-access-2020/2020-02-18T10:20:12+00:00https://www.pembrokeconsulting.com/specialty-pharmacy-ma-in-2019-cvs-optumrx-and-private-equity-highlight-a-slowing-market/2020-02-19T11:40:06+00:00https://www.pembrokeconsulting.com/connecting-the-dots-for-specialty-medications-improving-provider-workflows-through-technology/2020-02-21T10:55:02+00:00https://www.pembrokeconsulting.com/informa-connect-cbis-5th-annual-idn-and-biopharma-partnering-summit/2020-02-24T11:24:50+00:00https://www.pembrokeconsulting.com/latest-express-scripts-data-slow-drug-spending-growth-and-big-plan-savings-from-manufacturer-copay-programs/2020-02-25T12:15:44+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-february-2020-amazon-care-generics-in-part-d-rebates-vs-list-prices-walmart-health-and-cheetos/2020-02-27T12:41:16+00:00https://www.pembrokeconsulting.com/join-me-for-asembias-specialty-pharmacy-summit-2020/2020-03-02T12:34:03+00:00https://www.pembrokeconsulting.com/the-top-15-u-s-pharmacies-of-2019-specialty-drugs-drive-the-industrys-evolution/2020-03-03T12:35:34+00:00https://www.pembrokeconsulting.com/insights-into-prescription-decision-support-through-the-patient-journey/2020-03-06T13:33:35+00:00https://www.pembrokeconsulting.com/informa-connect-cbis-pcc-2020-the-17th-annual-pharmaceutical-compliance-congress/2020-03-09T11:36:30+00:00https://www.pembrokeconsulting.com/new-the-2020-economic-report-on-u-s-pharmacies-and-pharmacy-benefit-managers/2020-03-10T11:43:17+00:00https://www.pembrokeconsulting.com/informa-connect-cbis-patient-support-services-congress/2020-03-16T11:38:21+00:00https://www.pembrokeconsulting.com/the-drug-channels-coronavirus-industry-impact-survey/2020-03-17T11:39:27+00:00https://www.pembrokeconsulting.com/three-things-to-look-for-in-a-patient-assistance-program/2020-03-20T11:32:56+00:00https://www.pembrokeconsulting.com/informa-connect-cbis-22nd-annual-medicaid-and-government-pricing-congress/2020-03-23T11:34:02+00:00https://www.pembrokeconsulting.com/coronavirus-industry-impact-patients-pharmacies-and-wholesalers-part-1/2020-03-24T11:36:41+00:00https://www.pembrokeconsulting.com/coronavirus-industry-impact-manufacturers-public-policy-and-payers-part-2/2020-03-25T11:40:22+00:00https://www.pembrokeconsulting.com/coronavirus-industry-impact-survey-winners-and-losers-part-3/2020-03-26T11:46:25+00:00https://www.pembrokeconsulting.com/expanding-how-covermymeds-helps-patients-access-their-medications/2020-03-27T11:48:26+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-march-2020-sanofis-gross-to-net-bubble-drug-pricing-findings-amazon-replaces-express-scripts-and-drug-channels-video/2020-03-31T11:34:15+00:00https://www.pembrokeconsulting.com/the-latest-cms-outlook-for-drug-spending-and-how-covid-19-will-change-it/2020-04-07T11:42:49+00:00https://www.pembrokeconsulting.com/introducing-drug-channels-video/2020-04-09T11:32:19+00:00https://www.pembrokeconsulting.com/industry-update-and-covid-19-impact-join-me-for-two-live-video-webinars-may-1-and-may-8/2020-04-14T13:45:20+00:00https://www.pembrokeconsulting.com/four-unexpected-ways-that-the-covid-19-medicaid-boom-will-affect-pbm-and-pharmacy-profits/2020-04-16T01:45:33+00:00https://www.pembrokeconsulting.com/what-is-payer-intelligence-and-how-can-it-be-combined-with-technology-to-enhance-patient-access/2020-04-17T12:46:12+00:00https://www.pembrokeconsulting.com/three-early-signs-that-covid-19-could-disrupt-the-buy-and-bill-channel/2020-04-21T11:51:49+00:00https://www.pembrokeconsulting.com/medication-access-during-uncertain-times-improving-provider-workflows-to-help-patients-in-need/2020-04-24T11:51:11+00:00https://www.pembrokeconsulting.com/the-top-15-specialty-pharmacies-of-2019-pbms-stay-on-top/2020-04-28T11:39:53+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-april-2020-drug-pricing-outlook-covid-19-data-tracker-community-oncology-clinics-and-my-favorite-chart-of-2020/2020-04-30T13:17:21+00:00https://www.pembrokeconsulting.com/elsevier-challenges-and-trends-to-watch-in-2020-guest-post/2020-05-01T11:44:35+00:00https://www.pembrokeconsulting.com/insurers-pbms-specialty-pharmacies-providers-will-vertical-consolidation-disrupt-drug-channels-in-2020-rerun/2020-05-04T11:33:08+00:00https://www.pembrokeconsulting.com/express-scripts-prime-therapeutics-our-four-takeaways-from-this-market-changing-deal-rerun/2020-05-05T14:18:29+00:00https://www.pembrokeconsulting.com/why-part-d-plans-prefer-high-list-price-drugs-that-raise-costs-for-seniors-rerun/2020-05-06T11:31:46+00:00https://www.pembrokeconsulting.com/express-scripts-vs-cvs-health-five-lessons-from-the-2020-formulary-exclusions-and-some-thoughts-on-patient-impact-rerun/2020-05-07T11:30:58+00:00https://www.pembrokeconsulting.com/surprise-brand-name-drug-prices-fell-in-2019-rerun/2020-05-08T11:47:36+00:00https://www.pembrokeconsulting.com/the-state-of-retail-pharmacy-2020-video/2020-05-12T11:37:22+00:00https://www.pembrokeconsulting.com/the-state-of-specialty-pharmacy-in-2020-video/2020-05-14T11:29:22+00:00https://www.pembrokeconsulting.com/copay-maximizers-are-displacing-accumulators-but-cms-ignores-how-payers-leverage-patient-support/2020-05-19T13:37:47+00:00https://www.pembrokeconsulting.com/why-do-cvs-and-express-scripts-rely-on-secretive-private-companies-to-run-their-copay-maximizer-programs/2020-05-21T11:51:22+00:00https://www.pembrokeconsulting.com/electronic-prescription-management-and-enrollment-for-specialty-medications-expanding-provider-adoption-of-tech-enabled-hub-services/2020-05-22T11:35:29+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-may-2020-covid-19-and-formularies-retail-to-mail-trends-abc-on-biosimilars-and-social-distancing-the-cvs-way/2020-05-27T11:38:22+00:00https://www.pembrokeconsulting.com/visit-asembias-specialty-pharmacy-summit-virtual-experience/2020-06-01T11:49:59+00:00https://www.pembrokeconsulting.com/pharmacist-job-market-in-2019-salaries-grew-retail-to-hospital-employment-shift-accelerated/2020-06-03T11:07:29+00:00https://www.pembrokeconsulting.com/new-hrsa-data-340b-program-reached-29-9-billion-in-2019-now-over-8-of-drug-sales/2020-06-09T11:45:41+00:00https://www.pembrokeconsulting.com/the-ripple-effect-of-medication-access-barriers-disruption-to-stakeholder-workflows-damage-to-brand-perception-and-detriment-to-innovation/2020-06-12T11:47:34+00:00https://www.pembrokeconsulting.com/pbms-and-drug-spending-in-2019-cvs-health-and-express-scripts-outperform-prime-therapeutics/2020-06-16T11:46:06+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-june-2020-cvss-new-gpo-cms-on-copay-accumulators-goodrx-fees-supermarket-pharmacies-and-mercks-ken-frazier/2020-06-24T11:44:46+00:00https://www.pembrokeconsulting.com/the-top-15-u-s-pharmacies-of-2019-specialty-drugs-drive-the-industrys-evolution-rerun/2020-07-06T11:43:58+00:00https://www.pembrokeconsulting.com/pharmacy-dir-fees-hit-a-record-9-billion-in-2019-thats-18-of-total-medicare-part-d-rebates-rerun/2020-07-07T11:43:03+00:00https://www.pembrokeconsulting.com/four-unexpected-ways-that-the-covid-19-medicaid-boom-will-affect-pbm-and-pharmacy-profits-rerun/2020-07-08T12:40:18+00:00https://www.pembrokeconsulting.com/the-top-15-specialty-pharmacies-of-2019-pbms-stay-on-top-rerun/2020-07-09T13:15:05+00:00https://www.pembrokeconsulting.com/cms-best-price-proposal-and-copay-assistance-how-new-rule-could-change-the-access-landscape/2020-07-10T11:36:44+00:00https://www.pembrokeconsulting.com/walgreens-and-cvs-top-the-28000-pharmacies-profiting-from-the-340b-program-will-the-unregulated-party-end/2020-07-14T11:16:10+00:00https://www.pembrokeconsulting.com/pbm-owned-specialty-pharmacies-expand-their-role-in-and-profits-from-the-340b-program/2020-07-21T11:38:21+00:00https://www.pembrokeconsulting.com/how-hospitals-and-pbms-profit-and-patients-lose-from-340b-contract-pharmacies/2020-07-23T11:53:45+00:00https://www.pembrokeconsulting.com/clarity-in-the-face-of-covid-19-building-an-effective-patient-savings-strategy/2020-07-24T11:46:05+00:00https://www.pembrokeconsulting.com/trumps-executive-orders-on-drug-pricing-the-drug-channels-guide-to-industry-implications/2020-07-27T00:31:54+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-july-2020-diabetes-costs-regenerons-copay-support-ma-rethinks-coupons-my-favorite-chart-updated-and-abcs-steve-collis/2020-07-29T11:36:09+00:00https://www.pembrokeconsulting.com/the-gross-to-net-bubble-hit-175-billion-in-2019-why-patients-need-rebate-reform/2020-08-04T10:48:12+00:00https://www.pembrokeconsulting.com/nasp-2020-annual-meeting-expo-virtual-experience/2020-08-03T11:33:29+00:00https://www.pembrokeconsulting.com/patient-assistance-programs-weathering-covid-19-and-the-unknown/2020-08-07T11:50:34+00:00https://www.pembrokeconsulting.com/five-top-drugmakers-reveal-list-vs-net-price-gaps-plus-the-trouble-with-insulin-prices/2020-08-11T17:57:26+00:00https://www.pembrokeconsulting.com/using-technology-to-improve-medication-access-and-impact-more-patients/2020-08-14T11:55:11+00:00https://www.pembrokeconsulting.com/hospitals-continue-their-startling-expansion-into-specialty-pharmacy/2020-08-18T12:24:32+00:00https://www.pembrokeconsulting.com/improve-compliance-and-create-transparency-with-340b-rebates-free-webinar/2020-08-21T11:41:38+00:00https://www.pembrokeconsulting.com/five-surprising-facts-about-covid-19-prescription-trends-for-retail-and-mail-pharmacies/2020-08-26T18:36:51+00:00https://www.pembrokeconsulting.com/the-connectiverx-non-commercial-pharmacy-maximize-your-patient-access-strategy/2020-08-28T16:42:54+00:00https://www.pembrokeconsulting.com/how-goodrx-profits-from-our-broken-pharmacy-pricing-system/2020-08-31T11:41:59+00:00https://www.pembrokeconsulting.com/pbms-and-drug-spending-in-2019-cvs-health-and-express-scripts-outperform-prime-therapeutics-rerun/2020-09-01T11:36:15+00:00https://www.pembrokeconsulting.com/walgreens-and-cvs-top-the-28000-pharmacies-profiting-from-the-340b-program-will-the-unregulated-party-end-rerun/2020-09-02T11:35:38+00:00https://www.pembrokeconsulting.com/copay-maximizers-are-displacing-accumulators-but-cms-ignores-how-payers-leverage-patient-support-rerun/2020-09-03T11:35:48+00:00https://www.pembrokeconsulting.com/why-do-cvs-and-express-scripts-rely-on-secretive-private-companies-to-run-their-copay-maximizer-programs-rerun/2020-09-04T11:41:42+00:00https://www.pembrokeconsulting.com/the-state-of-specialty-pharmacy-2020-market-data-and-trends-video/2020-09-09T11:15:37+00:00https://www.pembrokeconsulting.com/why-generic-medicines-are-especially-good-for-the-u-s-right-now/2020-09-10T11:46:48+00:00https://www.pembrokeconsulting.com/new-for-2021-the-drug-channels-quarterly-video-webinar-series/2020-09-14T11:51:17+00:00https://www.pembrokeconsulting.com/my-wall-street-journal-op-ed-about-the-340b-program/2020-09-15T11:45:43+00:00https://www.pembrokeconsulting.com/three-ways-to-boost-patient-access-to-orphan-drugs-with-an-independent-specialty-pharmacy/2020-09-18T17:29:16+00:00https://www.pembrokeconsulting.com/15th-hub-spp-and-eservices-summit/2020-09-21T11:21:12+00:00https://www.pembrokeconsulting.com/preorder-now-the-2020-21-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2020-09-22T11:20:31+00:00https://www.pembrokeconsulting.com/specialty-pharmacy-keeps-disrupting-buy-and-bill-and-covid-19-will-accelerate-it/2020-09-23T11:38:10+00:00https://www.pembrokeconsulting.com/mapping-the-specialty-medication-journey-digital-patient-engagement-made-easy/2020-09-25T11:39:37+00:00https://www.pembrokeconsulting.com/informa-connect-cbis-8th-annual-coupon-and-copay-forum/2020-09-29T11:38:16+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-september-2020-fqhcs-and-340b-drug-prices-cvs-healths-zinc-telehealth-all-time-greatest-songs-and-10k-on-twitter/2020-09-30T14:58:03+00:00https://www.pembrokeconsulting.com/bridging-data-insights-across-the-patient-journey-to-inform-your-commercialization-strategy/2020-10-02T11:49:11+00:00https://www.pembrokeconsulting.com/the-booming-biosimilar-market-of-2020/2020-10-06T11:41:24+00:00https://www.pembrokeconsulting.com/discriminatory-reimbursement-practices-by-pbms-represent-a-threat-to-public-health-a-perspective-from-community-health/2020-10-09T11:36:40+00:00https://www.pembrokeconsulting.com/informa-connect-cbis-6th-edition-drug-pricing-transparency-congress-2/2020-10-12T11:23:53+00:00https://www.pembrokeconsulting.com/new-the-2020-21-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2020-10-13T12:05:24+00:00https://www.pembrokeconsulting.com/prime-therapeutics-deepens-its-reliance-on-express-scripts-our-four-takeaways-from-their-new-pharmacy-relationship/2020-10-15T11:40:45+00:00https://www.pembrokeconsulting.com/utilizing-gini-coefficient-to-anticipate-price-movement-drug-shortages-and-pricing-elasticity/2020-10-16T11:22:28+00:00https://www.pembrokeconsulting.com/16th-annual-life-sciences-trade-and-channel-strategies/2020-10-19T11:30:10+00:00https://www.pembrokeconsulting.com/preferred-pharmacy-networks-dominate-in-2021-medicare-part-d-plans-the-scoop-on-cigna-cvs-health-humana-wellcare-and-more/2020-10-20T11:36:03+00:00https://www.pembrokeconsulting.com/a-primer-on-340b-contract-pharmacies-and-medicaid-duplicate-discounts-video/2020-10-22T11:47:26+00:00https://www.pembrokeconsulting.com/new-payer-policies-introduce-copay-accumulators-to-medical-benefit-products-implications-for-manufacturer-programs/2020-10-23T11:37:40+00:00https://www.pembrokeconsulting.com/gtn-2020-informa-connect-cbis-gross-to-net-summit/2020-10-26T11:30:04+00:00https://www.pembrokeconsulting.com/battle-of-the-giants-cvs-kroger-walgreens-and-walmart-expand-in-2021-part-d-preferred-networks/2020-10-27T11:37:22+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-october-2020-accumulator-nonsense-goodrx-fees-340b-dollars-and-our-simulated-world/2020-10-29T11:34:33+00:00https://www.pembrokeconsulting.com/rare-disease-innovation-and-partnering-summit-2020/2020-11-02T11:48:53+00:00https://www.pembrokeconsulting.com/independent-pharmacies-learn-to-live-with-and-without-preferred-networks-for-2021/2020-11-03T16:07:53+00:00https://www.pembrokeconsulting.com/what-i-told-congress-about-the-340b-program/2020-11-05T06:41:57+00:00https://www.pembrokeconsulting.com/employer-pharmacy-benefits-2020-some-good-coinsurance-news-but-many-still-face-prescription-list-prices/2020-11-11T05:22:36+00:00https://www.pembrokeconsulting.com/saveonsps-copay-maximizer-failed-me-a-patients-perspective/2020-11-13T12:40:37+00:00https://www.pembrokeconsulting.com/new-drug-channels-outlook-2021-live-video-webinar/2020-11-16T12:41:58+00:00https://www.pembrokeconsulting.com/copay-accumulator-and-maximizer-update-adoption-accelerating-as-pushback-grows/2020-11-17T12:31:44+00:00https://www.pembrokeconsulting.com/disruption-delayed-making-sense-of-amazons-latest-pharmacy-moves/2020-11-19T04:27:42+00:00https://www.pembrokeconsulting.com/informa-connects-16th-annual-commercial-contracts-chargebacks/2020-11-23T12:49:53+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-november-2020-rebate-rule-redux-mfn-maybe-amazons-pharmacy-customers-drug-spending-gpo-ma-and-rxtrace/2020-11-24T12:40:08+00:00https://www.pembrokeconsulting.com/medicaid-and-government-pricing-congress/2020-11-30T14:33:41+00:00https://www.pembrokeconsulting.com/six-crucial-trends-facing-u-s-drug-wholesalers/2020-12-01T21:50:33+00:00https://www.pembrokeconsulting.com/drug-pricing-policy-in-2021-four-crucial-consequences-of-pharmacy-benefits-today/2020-12-08T13:23:08+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-december-2020-340b-pharmacy-profits-pre-amazon-pillpack-physicians-vs-accumulators-maines-importation-fail-and-vaccine-humor/2020-12-10T12:47:45+00:00https://www.pembrokeconsulting.com/how-real-world-data-is-helping-speed-oncology-drug-development/2020-12-11T12:39:59+00:00https://www.pembrokeconsulting.com/prime-therapeutics-deepens-its-reliance-on-express-scripts-our-four-takeaways-from-their-new-pharmacy-relationship-rerun/2020-12-14T12:39:10+00:00https://www.pembrokeconsulting.com/how-goodrx-profits-from-our-broken-pharmacy-pricing-system-rerun/2020-12-15T12:48:26+00:00https://www.pembrokeconsulting.com/my-wall-street-journal-op-ed-about-the-340b-program-rerun/2020-12-16T12:24:54+00:00https://www.pembrokeconsulting.com/the-booming-biosimilar-market-of-2020-rerun/2020-12-17T12:39:18+00:00https://www.pembrokeconsulting.com/specialty-pharmacy-keeps-disrupting-buy-and-bill-and-covid-19-will-accelerate-it-rerun/2020-12-18T12:34:43+00:00https://www.pembrokeconsulting.com/16th-hub-and-spp-model-optimization-spring-stakeholder-summit/2021-01-04T12:20:33+00:00https://www.pembrokeconsulting.com/surprise-brand-name-drug-prices-fell-again-in-2020/2021-01-05T19:12:28+00:00https://www.pembrokeconsulting.com/preserving-trusted-brand-prescribing-through-the-patient-journey/2021-01-08T11:37:33+00:00https://www.pembrokeconsulting.com/pap-critical-update/2021-01-11T11:57:02+00:00https://www.pembrokeconsulting.com/the-big-three-pbms-ramp-up-specialty-drug-exclusions-for-2021/2021-01-12T11:57:28+00:00https://www.pembrokeconsulting.com/u-s-prescription-trends-2020-review-and-2021-outlook-video/2021-01-14T11:51:11+00:00https://www.pembrokeconsulting.com/17th-annual-life-sciences-accounting-reporting-congress/2021-01-19T11:30:01+00:00https://www.pembrokeconsulting.com/latest-cms-data-reveal-the-truth-about-u-s-drug-spending/2021-01-20T14:34:58+00:00https://www.pembrokeconsulting.com/enhance-patient-care-and-cost-savings-by-improving-data-exchange-within-the-systems-you-already-have/2021-01-22T12:49:59+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-january-2021-hospital-drug-profits-details-of-pbm-manufacturer-insulin-deals-and-my-favorite-chart-updated/2021-01-26T12:25:54+00:00https://www.pembrokeconsulting.com/the-importance-of-humanity-in-medication-access/2021-01-29T12:05:09+00:00https://www.pembrokeconsulting.com/pharmacy-economics-rebound-a-little-amid-glimmers-of-good-news/2021-02-03T12:45:25+00:00https://www.pembrokeconsulting.com/available-for-preorder-the-2021-economic-report-on-u-s-pharmacies-and-pharmacy-benefit-managers/2021-02-09T12:31:11+00:00https://www.pembrokeconsulting.com/the-promise-and-limits-of-digital-pharmacies/2021-02-16T20:44:49+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-february-2021-accumulator-problems-humana-esi-white-bagging-battles-buy-and-bill-economics-and-pharmacy-hero-dave-marley/2021-02-23T21:01:08+00:00https://www.pembrokeconsulting.com/supermarkets-outpace-cvs-and-walgreens-in-2021s-part-d-pharmacy-networks/2021-03-02T19:17:36+00:00https://www.pembrokeconsulting.com/new-drug-channels-quarterly-update-patients-payers-and-pbms-live-video-webinar/2021-03-04T12:48:18+00:00https://www.pembrokeconsulting.com/the-top-15-u-s-pharmacies-of-2020-market-shares-and-revenues-at-the-biggest-companies/2021-03-09T12:53:02+00:00https://www.pembrokeconsulting.com/predicting-payer-uptake-with-precision/2021-03-12T12:55:29+00:00https://www.pembrokeconsulting.com/new-the-2021-economic-report-on-u-s-pharmacies-and-pharmacy-benefit-managers/2021-03-16T11:50:03+00:00https://www.pembrokeconsulting.com/how-goodrxs-rapid-growth-creates-conflict-between-pbms-and-payers/2021-03-18T11:48:41+00:00https://www.pembrokeconsulting.com/reducing-patient-fallout-transform-how-they-get-and-stay-on-medication/2021-03-19T11:19:27+00:00https://www.pembrokeconsulting.com/the-big-three-pbms-ramp-up-specialty-drug-exclusions-for-2021-rerun/2021-03-22T10:56:10+00:00https://www.pembrokeconsulting.com/surprise-brand-name-drug-prices-fell-again-in-2020-rerun/2021-03-23T11:27:32+00:00https://www.pembrokeconsulting.com/disruption-delayed-making-sense-of-amazons-latest-pharmacy-moves-rerun/2021-03-24T11:30:02+00:00https://www.pembrokeconsulting.com/drug-pricing-policy-in-2021-four-crucial-consequences-of-pharmacy-benefits-today-rerun/2021-03-25T11:20:34+00:00https://www.pembrokeconsulting.com/what-i-told-congress-about-the-340b-program-rerun/2021-03-26T11:16:32+00:00https://www.pembrokeconsulting.com/informa-connects-medicaid-and-government-pricing-congress/2021-03-31T13:46:57+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-march-2021-sanofis-gross-to-net-bubble-express-scripts-rebates-health-insurance-hustle-and-vertical-integration-illustrated/2021-03-31T11:22:50+00:00https://www.pembrokeconsulting.com/streamlining-the-specialty-therapy-prescribing-and-enrollment-experience/2021-04-01T11:50:19+00:00https://www.pembrokeconsulting.com/the-top-pharmacy-benefit-managers-of-2020-vertical-integration-drives-consolidation/2021-04-06T11:09:13+00:00https://www.pembrokeconsulting.com/a-framework-to-optimize-patient-access-and-drive-value-in-the-care-continuum/2021-04-09T10:23:08+00:00https://www.pembrokeconsulting.com/informa-connects-patient-support-services-congress/2021-04-12T04:00:00+00:00https://www.pembrokeconsulting.com/gross-to-net-bubble-update-net-prices-drop-again-at-six-top-drugmakers/2021-04-14T05:29:15+00:00https://www.pembrokeconsulting.com/choosing-the-optimal-pharmacy-model-for-retail-and-specialty-lite-products/2021-04-16T11:31:55+00:00https://www.pembrokeconsulting.com/informa-connects-compliance-congress-for-specialty-products/2021-04-19T11:00:00+00:00https://www.pembrokeconsulting.com/express-scripts-2020-update-utilization-drove-drug-spending-growth-while-maximizers-gained-further-traction/2021-04-20T12:23:37+00:00https://www.pembrokeconsulting.com/the-value-of-patient-centricity-in-tech-enabled-medication-access-solutions/2021-04-23T20:26:19+00:00https://www.pembrokeconsulting.com/making-health-policy-work-for-patients-how-platform-solutions-enable-more-affordable-drugs-kalderos/2021-04-26T11:05:31+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-april-2021-cignas-500-gift-340b-specialty-pharmacy-goodrx-deep-dive-and-u-s-drug-pricing-policy/2021-04-27T12:44:27+00:00https://www.pembrokeconsulting.com/how-non-commercial-pharmacies-accelerate-patients-into-prescription-programs/2021-04-30T11:32:24+00:00https://www.pembrokeconsulting.com/informa-connects-annual-commercial-contracts-chargebacks-congress/2021-05-03T11:00:00+00:00https://www.pembrokeconsulting.com/dcis-top-15-specialty-pharmacies-of-2020-pbms-expand-amid-the-shakeout-while-walgreens-outlook-dims/2021-05-04T11:05:02+00:00https://www.pembrokeconsulting.com/predicting-enrollment-changes-in-the-covid-era/2021-05-07T11:50:33+00:00https://www.pembrokeconsulting.com/informa-connects-formulary-reimbursement-and-access-summit-2021/2021-05-10T11:00:00+00:00https://www.pembrokeconsulting.com/how-cignas-growing-pharmacy-platform-expands-its-channel-power/2021-05-12T11:11:08+00:00https://www.pembrokeconsulting.com/prescribing-and-policy-trends-affecting-medication-access-in-2021/2021-05-14T11:06:11+00:00https://www.pembrokeconsulting.com/lexisnexis-webinar-using-sdoh-data-to-supercharge-outreach-and-engagement/2021-05-17T11:00:00+00:00https://www.pembrokeconsulting.com/the-specialty-pharmacy-accreditation-boom-slows-dcis-exclusive-update-on-the-u-s-market/2021-05-18T11:26:16+00:00https://www.pembrokeconsulting.com/six-trends-to-watch-in-the-new-healthcare-economy/2021-05-21T04:38:34+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-may-2021-340b-pbms-benefit-design-problems-overworked-pharmacists-hospitals-keep-grabbing-physicians-and-new-patent-games/2021-05-25T11:27:17+00:00https://www.pembrokeconsulting.com/new-drug-channels-update-340b-controversies-and-outlook-live-video-webinar/2021-06-01T11:00:00+00:00https://www.pembrokeconsulting.com/how-cvs-health-drives-mckessons-distribution-financials/2021-06-02T10:47:26+00:00https://www.pembrokeconsulting.com/technology-and-human-care-combine-to-support-the-medication-access-journey/2021-06-04T11:05:27+00:00https://www.pembrokeconsulting.com/national-association-of-specialty-pharmacy-nasp-2021-annual-meeting-expo/2021-06-07T16:02:20+00:00https://www.pembrokeconsulting.com/pharmacist-job-market-in-2020-hospital-employment-up-retail-salaries-down/2021-06-08T11:11:58+00:00https://www.pembrokeconsulting.com/the-top-five-considerations-when-choosing-a-patient-solutions-provider/2021-06-11T10:38:00+00:00https://www.pembrokeconsulting.com/informa-connects-18th-life-sciences-accounting-reporting-congress/2021-06-14T11:00:00+00:00https://www.pembrokeconsulting.com/exclusive-340b-continues-its-unbridled-takeover-of-pharmacies-and-pbms/2021-06-15T11:00:30+00:00https://www.pembrokeconsulting.com/exclusive-the-340b-program-soared-to-38-billion-in-2020-up-27-vs-2019/2021-06-16T11:01:32+00:00https://www.pembrokeconsulting.com/informa-connects-idn-biopharma-partnering-summit/2021-06-21T10:30:00+00:00https://www.pembrokeconsulting.com/the-top-pharmacy-benefit-managers-of-2020-vertical-integration-drives-consolidation-rerun/2021-06-22T11:21:22+00:00https://www.pembrokeconsulting.com/how-goodrxs-rapid-growth-creates-conflict-between-pbms-and-payers-rerun/2021-06-23T10:54:10+00:00https://www.pembrokeconsulting.com/gross-to-net-bubble-update-net-prices-drop-again-at-six-top-drugmakers-rerun/2021-06-25T10:55:18+00:00https://www.pembrokeconsulting.com/the-top-15-u-s-pharmacies-of-2020-market-shares-and-revenues-at-the-biggest-companies-rerun/2021-06-24T11:26:31+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-june-2021-amazons-latest-patients-vs-accumulators-generics-biosimilars-340b-games-and-a-hospital-road-trip/2021-06-28T04:19:19+00:00https://www.pembrokeconsulting.com/rite-aids-pbm-strategy-will-hope-triumph-over-experience/2021-07-07T10:51:13+00:00https://www.pembrokeconsulting.com/informa-connects-pap-patient-assistance-access-programs/2021-07-12T10:49:59+00:00https://www.pembrokeconsulting.com/pbms-and-drug-spending-in-2020-data-from-cvs-health-sort-of-express-scripts-navitus-and-welldyne-plus-the-demise-of-pbm-reporting/2021-07-14T10:48:24+00:00https://www.pembrokeconsulting.com/the-power-of-partnerships-why-pharma-needs-to-redefine-its-role-with-idns/2021-07-16T10:58:37+00:00https://www.pembrokeconsulting.com/informa-connects-finance-and-accounting-for-bioscience-companies-hybrid-events/2021-07-19T10:30:00+00:00https://www.pembrokeconsulting.com/specialty-pharmacys-explosive-340b-growth/2021-07-20T10:44:34+00:00https://www.pembrokeconsulting.com/informa-connects-hub-spp-and-eservices-optimization/2021-07-26T10:30:00+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-july-2021-stingy-hospitals-biosimilars-part-b-hep-c-drug-prices-costco-vs-part-d-and-mba-funny-business/2021-07-27T10:48:15+00:00https://www.pembrokeconsulting.com/expanding-healthcare-technology-across-the-care-team-to-improve-medication-access/2021-07-30T11:51:45+00:00https://www.pembrokeconsulting.com/drug-channels-recommends-the-u-s-healthcare-ecosystem-payers-providers-producers/2021-08-03T11:35:00+00:00https://www.pembrokeconsulting.com/informa-connects-medicaid-drug-rebate-program-mdrp-2021-hybrid/2021-08-09T10:30:00+00:00https://www.pembrokeconsulting.com/part-b-update-hospitals-keep-displacing-physicians-and-more-practice-acquisitions-loom/2021-08-11T10:54:10+00:00https://www.pembrokeconsulting.com/three-factors-to-determine-the-best-e-support-services-provider-for-your-brand/2021-08-13T10:57:03+00:00https://www.pembrokeconsulting.com/informa-connects-coupon-copay/2021-08-14T15:12:27+00:00https://www.pembrokeconsulting.com/why-goodrx-not-amazon-may-be-the-true-pbm-disrupter/2021-08-17T15:42:25+00:00https://www.pembrokeconsulting.com/leveraging-mobile-patient-support-to-boost-adherence/2021-08-20T16:21:39+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-august-2021-optumrxs-new-gpo-pharmacy-dir-fees-state-biosimilar-laws-um-views-and-a-newspaper-delivers/2021-08-25T12:06:03+00:00https://www.pembrokeconsulting.com/a-video-history-of-pharmacies-and-prescription-prices-from-soda-fountains-to-goodrx/2021-08-31T10:57:23+00:00https://www.pembrokeconsulting.com/drug-channels-update-buy-and-bill-market-trends-new-live-video-webinar/2021-09-08T11:32:59+00:00https://www.pembrokeconsulting.com/improving-the-provider-experience-to-accelerate-patients-access-to-specialty-therapy/2021-09-10T10:19:39+00:00https://www.pembrokeconsulting.com/how-cvs-health-drives-cardinal-healths-distribution-financials/2021-09-09T11:14:15+00:00https://www.pembrokeconsulting.com/informa-connects-drug-pricing-transparency-congress/2021-09-13T11:11:26+00:00https://www.pembrokeconsulting.com/available-for-preorder-the-2021-22-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2021-09-14T11:09:48+00:00https://www.pembrokeconsulting.com/how-and-why-i-was-overcharged-by-penn-medicine-and-my-blue-cross-health-plan-a-true-story/2021-09-15T12:05:23+00:00https://www.pembrokeconsulting.com/connected-solutions-are-simplifying-specialty-medication-access/2021-09-17T11:15:17+00:00https://www.pembrokeconsulting.com/informa-connects-pharmabiotech-gtn-summit/2021-09-20T10:30:00+00:00https://www.pembrokeconsulting.com/dcis-top-15-specialty-pharmacies-of-2020-pbms-expand-amid-the-shakeout-while-walgreens-outlook-dims-rerun/2021-09-21T11:22:13+00:00https://www.pembrokeconsulting.com/exclusive-the-340b-program-soared-to-38-billion-in-2020-up-27-vs-2019-rerun/2021-09-22T11:16:39+00:00https://www.pembrokeconsulting.com/how-cignas-growing-pharmacy-platform-expands-its-channel-power-rerun/2021-09-23T11:32:52+00:00https://www.pembrokeconsulting.com/pharmacist-job-market-in-2020-hospital-employment-up-retail-salaries-down-rerun/2021-09-24T10:44:09+00:00https://www.pembrokeconsulting.com/informa-connects-trade-channel-strategies/2021-09-27T10:55:20+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-september-2021-hospitals-340b-profits-drug-prices-deflate-u-s-vs-eu-amazon-vs-cvs-and-more-bad-blood-for-theranos/2021-09-28T10:56:34+00:00https://www.pembrokeconsulting.com/small-pharmacies-continue-to-run-away-from-medicare-part-ds-preferred-networks/2021-11-18T12:29:22+00:00https://www.pembrokeconsulting.com/cvs-walgreens-walmart-and-supermarkets-keep-position-in-2022-part-d-preferred-networks-with-a-little-help-from-340b/2021-11-16T12:26:03+00:00https://www.pembrokeconsulting.com/drug-channels-outlook-2022-new-live-video-webinar/2021-11-15T11:53:02+00:00https://www.pembrokeconsulting.com/why-pbms-and-payers-are-embracing-insulin-biosimilars-with-higher-prices-and-what-that-means-for-humira/2021-11-09T16:30:07+00:00https://www.pembrokeconsulting.com/pathway-or-perish-the-two-pronged-hurdle-to-ensuring-access-in-oncology/2021-11-19T12:46:05+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-november-2021-health-plans-and-insulin-gross-to-net-bubble-update-cvs-340b-and-amazon-redux/2021-11-27T04:05:59+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-november-2021-specialty-pharmacy-health-plans-and-insulin-gross-to-net-bubble-update-cvs-340b-and-amazon-redux/2021-11-30T10:34:51+00:00https://www.pembrokeconsulting.com/cvs-pharmacy-downsizes-10-industry-trends-driving-the-retail-shakeout/2021-12-01T07:00:00+00:00https://www.pembrokeconsulting.com/drug-channels-recommends-uncontrolled-spread-by-scott-gottlieb/2021-12-03T07:18:23+00:00https://www.pembrokeconsulting.com/better-data-better-outcomes-a-lexisnexis-risk-solutions-and-q1-productions-webinar/2021-12-06T05:30:00+00:00https://www.pembrokeconsulting.com/employer-pharmacy-benefits-2021-patient-specialty-costs-rise-with-coinsurance-and-accumulators/2021-12-07T11:55:07+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-june-2025-pbm-rebate-flow-340bs-2024-boom-ira-fallout-mfn-legal-risks-and-mark-cubans-pbm-rant/2025-06-24T10:30:00+00:00https://www.pembrokeconsulting.com/transparency-vs-reality-troubling-lessons-from-pbm-disclosure-laws-rerun/2025-06-20T10:30:00+00:00https://www.pembrokeconsulting.com/mapping-the-vertical-integration-of-insurers-pbms-specialty-pharmacies-and-providers-dcis-2025-update-and-competitive-outlook-rerun/2025-06-19T10:30:00+00:00https://www.pembrokeconsulting.com/the-top-15-specialty-pharmacies-of-2024-how-pbms-health-systems-and-independents-are-shaping-the-market-rerun/2025-06-18T10:30:00+00:00https://www.pembrokeconsulting.com/the-top-pharmacy-benefit-managers-of-2024-market-share-and-key-industry-developments-rerun/2025-06-17T10:30:00+00:00https://www.pembrokeconsulting.com/the-stelara-biosimilar-price-war-how-pbm-affiliated-private-labels-are-reshaping-the-market/2025-07-08T10:30:00+00:00https://www.pembrokeconsulting.com/rewriting-the-access-script-a-pharmacists-view-on-the-rise-of-direct-to-patient/2025-07-11T10:30:00+00:00https://www.pembrokeconsulting.com/gross-to-net-bubble-hits-356b-in-2024-but-growth-slows-to-10-year-low/2025-07-15T10:30:00+00:00https://www.pembrokeconsulting.com/informa-connects-medicaid-drug-rebate-program-summit/2025-07-21T10:30:00+00:00https://www.pembrokeconsulting.com/2024-gross-to-net-realities-at-9-top-drugmakers-a-new-era-of-market-access/2025-07-22T10:00:00+00:00https://www.pembrokeconsulting.com/beyond-throughput-building-reverification-strategies-that-safeguard-access/2025-07-25T10:30:00+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-july-2025-340b-vs-patients-humira-whiplash-accumulator-fallout-and-pharmacy-struggles/2025-07-29T10:30:00+00:00https://www.pembrokeconsulting.com/the-ai-advantage-evolving-patient-engagement-strategies-to-improve-outcomes/2025-08-01T11:54:00+00:00https://www.pembrokeconsulting.com/markup-madness-2025-hospitals-insurers-and-the-broken-buy-and-bill-market-for-biosimilars/2025-08-05T10:30:00+00:00https://www.pembrokeconsulting.com/patient-supports-perfect-storm-in-2025-hits-misses-and-surprises/2025-08-08T10:30:00+00:00https://www.pembrokeconsulting.com/pharmacy-shakeout-why-u-s-drugstores-are-disappearing/2025-08-12T10:30:00+00:00https://www.pembrokeconsulting.com/solving-the-gross-to-net-bubble-with-better-data/2025-08-15T11:42:00+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-august-2025-white-bagging-battles-private-label-price-hypocrisy-340b-patient-problems-and-unitedhealth-groups-woes/2025-08-19T10:30:00+00:00https://www.pembrokeconsulting.com/why-the-pharmacy-supply-chain-is-broken-and-how-smithrx-is-fixing-it/2025-08-22T11:43:00+00:00https://www.pembrokeconsulting.com/hubs-the-bridge-between-patients-and-providers/2025-08-29T10:30:00+00:00https://www.pembrokeconsulting.com/if-banks-sync-data-in-real-time-why-cant-patient-services/2025-09-05T04:30:00+00:00https://www.pembrokeconsulting.com/drug-channels-leadership-forum-2026-full-agenda-now-available-spoiler-even-more-awesome-than-2025/2025-09-09T04:30:00+00:00https://www.pembrokeconsulting.com/inside-rare-disease-pharmacy-lessons-in-personalizing-care/2025-09-12T10:30:00+00:00https://www.pembrokeconsulting.com/the-90-billion-leakage-problem-how-ris-rx-helps-pharma-recover-lost-revenue/2025-09-15T10:30:00+00:00https://www.pembrokeconsulting.com/preorder-now-dcis-2025-26-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2025-09-17T11:00:00+00:00https://www.pembrokeconsulting.com/inside-the-2025-psao-market-how-wholesalers-shape-pharmacy-pbm-relationships/2025-09-16T11:00:00+00:00https://www.pembrokeconsulting.com/cracking-the-code-of-bin-pcn-group-data-for-faster-benefit-verification/2025-09-19T10:30:00+00:00https://www.pembrokeconsulting.com/informa-connects-patient-support-services-congress-2/2025-09-22T11:00:00+00:00https://www.pembrokeconsulting.com/who-will-pay-for-prescription-drugs-in-2033-dcis-takeaways-from-the-latest-government-forecasts/2025-09-23T10:30:00+00:00https://www.pembrokeconsulting.com/pharmas-direct-to-consumer-future-runs-through-goodrx/2025-09-26T11:00:00+00:00https://www.pembrokeconsulting.com/informa-connects-copay-reimbursement-and-access-congress-2025/2025-09-29T10:30:00+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-september-2025-mark-cuban-wins-again-biosimilar-pricing-double-standards-part-d-collapse-fresh-340b-facts-and-the-pitt/2025-09-30T10:30:00+00:00https://www.pembrokeconsulting.com/reimagining-patient-access-building-direct-to-consumer-models-for-a-new-regulatory-era/2025-10-03T10:30:00+00:00https://www.pembrokeconsulting.com/informa-connects-pbm-contracting-summit/2025-10-06T10:30:00+00:00https://www.pembrokeconsulting.com/the-stelara-biosimilar-price-war-how-pbm-affiliated-private-labels-are-reshaping-the-market-rerun/2025-10-07T10:30:00+00:00https://www.pembrokeconsulting.com/2024-gross-to-net-realities-at-9-top-drugmakers-a-new-era-of-market-access-rerun/2025-10-08T10:30:00+00:00https://www.pembrokeconsulting.com/direct-to-patient-2-0-why-todays-dtp-programs-cant-scale-and-what-pharma-must-do-next/2025-10-10T11:00:00+00:00https://www.pembrokeconsulting.com/the-340b-contract-pharmacy-market-in-2025-big-chains-and-pbms-tighten-their-grip-rerun/2025-10-09T10:30:00+00:00https://www.pembrokeconsulting.com/informa-connects-pharma-biotech-gtn-summit/2025-10-13T11:00:00+00:00https://www.pembrokeconsulting.com/now-available-the-2025-26-economic-report-on-pharmaceutical-wholesalers-and-specialty-distributors/2025-10-14T11:00:00+00:00https://www.pembrokeconsulting.com/why-site-of-care-is-the-hidden-barrier-in-neurologys-bright-pipeline/2025-10-17T04:00:00+00:00https://www.pembrokeconsulting.com/informa-connects-trade-and-channel-strategies/2025-10-20T11:00:00+00:00https://www.pembrokeconsulting.com/the-future-of-buy-and-bill-market-access-five-drivers-of-wholesalers-vertical-integration-with-physician-practices/2025-10-21T11:00:00+00:00https://www.pembrokeconsulting.com/lets-be-direct-we-have-an-access-and-affordability-problem-to-solve/2025-10-24T10:30:00+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-october-2025-vertical-integration-woes-afps-gone-wild-part-ds-decline-340bloat-and-dr-gs-acip-haunting/2025-10-28T10:30:00+00:00https://www.pembrokeconsulting.com/cignas-rebate-free-pharmacy-model-three-realities-behind-its-latest-push-to-pop-the-gross-to-net-bubble/2025-10-29T11:00:00+00:00https://www.pembrokeconsulting.com/as-pharma-faces-financial-pressure-pharmacy-delivers-measurable-impact/2025-10-30T10:30:00+00:00https://www.pembrokeconsulting.com/hubs-ai-and-the-new-era-of-revenue-protection-in-patient-access/2025-11-07T05:00:00+00:00https://www.pembrokeconsulting.com/drug-channels-outlook-2026-live-webinar-with-adam-j-fein-ph-d-on-pbms-part-d-dtc-strategies-drug-policy-trends-and-more/2025-11-12T12:00:00+00:00https://www.pembrokeconsulting.com/medicare-part-d-2026-preferred-networks-vanish-as-the-pdp-market-collapses/2025-11-13T11:30:00+00:00https://www.pembrokeconsulting.com/the-700-copay-that-changed-everything/2025-11-14T11:30:00+00:00https://www.pembrokeconsulting.com/drug-channels-news-roundup-november-2025-pbm-revolution-cubans-stelara-challenge-express-scripts-price-games-u-s-drug-spending-reality-and-the-afp-reckoning/2025-11-18T05:30:00+00:00https://www.pembrokeconsulting.com/the-hidden-burdens-of-cancer-care-when-insurers-override-doctors/2025-11-20T07:17:00+00:00https://www.pembrokeconsulting.com/list-price-reductions-will-deflate-the-gross-to-net-bubble-and-threaten-pharmacy-and-340b-profits-from-ira-negotiated-drugs/2025-12-02T11:00:00+00:00https://www.pembrokeconsulting.com/closing-the-specialty-access-gap-how-goodrx-turns-intent-into-therapy-starts/2025-12-05T11:00:00+00:00https://www.pembrokeconsulting.com/how-large-pbms-make-money-today-a-2025-drug-channels-update-rerun/2025-12-08T11:30:00+00:00